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Abstract
Control systems, and, in particular, feedback control systems, have gained increasing importance
in biomedical applications over the last years. Such systems have been applied to the automatic
administration of anesthetics during surgical procedures, mainly with the purpose of achieving and
maintaining adequate levels for relevant physiological parameters.
Among their benefits are avoiding both overdosage and underdosage of the drugs, and conse-
quently minimizing the drug consumption, and reducing the effect of inter and intra individual
variability. Focused on these benefits, this thesis aims at giving further contributions to develop
control schemes for drug administration during general anesthesia. In this context two important
components of anesthesia will be considered: the neuromuscular blockade (NMB) and the depth
of anesthesia (DoA). The two components can be simulated by mathematical models with patient
parameters. The NMB is modelled as a single-input single-output system whereas the BIS level is
modelled as a multiple-input single-output.
In this thesis it is shown to be possible to obtain a good description of the process with a reduced
number of patient-dependent parameters in these models. Moreover efficient feedback controllers
are designed using these simplified models.
Two control laws will be presented: the first is based on techniques for the control of compart-
mental systems; the second control law is obtained by solving an optimal control problem (OCP)
with a positivity constraint in the input. Due to the complexity introduced by this positivity con-
straint, the OCP is relaxed into a semi-definite program (SDP) by replacing the original variables
by their moments up to a certain order. The optimal values of the moments are then computed by
a semi-definite programming solver.
The proposed control techniques are tested in different databases in order to compare their perfor-
mance and to validate their incorporation in clinical environment, through the plataform GALENO
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Resumo
Nos últimos anos, os sistemas de controlo e, em particular, o controlo por retroação tem recebido
crescente importância nas aplicações biomédicas. Um exemplo dessas aplicações é o controlo
automático da administração de fármacos em anestesia geral, com o objetivo de alcançar e manter
determinados níveis fisiológicos.
Entre as suas vantagens, está a de evitar a sob-dosagem e a sobre-dosagem e, consequentemente,
reduzir o consumo de fármacos e também o efeito da variabilidade inter e intra individual. Desta
forma, o objetivo desta tese é contribuir para o desenvolvimento de estratégias de controlo para
a administração automática durante anestesias gerais. Neste contexto, existem duas importantes
componentes a considerar: o nível de relaxamento (NMB) e a profundidade anestésica (DoA).
Estas duas componentes podem ser obtidas através de modelos matemáticos. Modelos estes, que
são dependentes de parâmetros do paciente. O NMB pode ser representado por um modelo de
uma entrada e uma saída e o DoA por um modelo de múltiplas entradas e uma saída.
Nesta tese é provado que é possível obter uma boa descrição dos processos com um número
reduzido de parâmetros dependentes do paciente. Os sistemas de controlo apresentados aqui serão
desenvolvidos tendo por base estes modelos simplificados.
Duas leis de controlo serão apresentadas: a primeira é baseada em técnicas de controlo para sis-
temas compartimentais; a segunda lei de controlo é obtida através da solução de um problema de
controlo ótimo com restrições de positividade. Devido à complexidade imposta por essa restrição,
o problema de controlo ótimo será relaxado num problema de programação semi-definida através
de uma mudança de variável. Mais concretamente, as variáveis originadas serão substituídas pelas
medidas matemáticas chamadas momentos. Os valores ótimos dos momentos serão determinados
por um solver de programação semi-definida.
As técnicas desenvolvidas foram testadas em diferentes bases de dados com o objetivo de comparar
os seus desempenhos e de validar a sua incorporação em ambiente clínico através da plataforma
GALENO 2.
2GALENO - Modeling and Control for personalized drug administration (www.fc.up.pt/galeno)
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1Introduction
Control systems, and, in particular, feedback control, have gained increasing importance in biomed-
ical applications over the last years. Feedback control systems use information from measurements
in order to determine a suitable input signal that achieves a desired goal. Such systems have been
applied to the automatic administration of anesthetics during surgical procedures, mainly with the
purpose of achieving and monitoring adequate levels for relevant physiological parameters, Men-
donça and Lago (1998), Lago et al. (2000). Among their benefits are avoiding both overdosage
and underdosage of the drugs, minimizing the drug consumption, and reducing the effect of inter
and intra individual variability. Focused on these benefits, this thesis aims at giving further con-
tributions to develop control schemes for drug administration during general anesthesia. In this
context two important components of anesthesia will be considered: the neuromuscular blockade
(NMB) and the depth of anesthesia (DoA).
In the clinical practice, anesthetics are administered following standard dosing guidelines often
based on an average patient, Bailey and Haddad (2005). The common procedure is to administer
an initial dose, observe the response, and adjust the dose according to the desired output (e.g.,
NMB and BIS levels). To reach an individualized dose the anesthesiologists need to understand
the pharmacokinetics (PK) and pharmacodynamics (PD) of the drugs in use, as well as possible
drug interaction. Pharmacokinetics studies the relation between the administrated drug dose and
the obtained plasmatic drug concentration, taking into account the absorption, the distribution and
the biotransformation of the drugs; pharmacodynamics relates the plasmatic drug concentration
with the actual drug effect on a patient, i.e., the physiological and biochemical effects of drugs
and their mechanism of action. The PK/PD models are a mathematical description of these re-
lationships and are the most used models Gambus and Trocóniz (2015). However, they involve
a high number of total patient-dependent parameters and the poor excitation of the input signals
(associated with this application) is not enough to achieve a good performance of the identifica-
tion methodologies. In order to overcome this difficulty, new Wiener models (i.e., consisting of a
dynamic linear part followed by a static nonlinearity) for the effect of the drugs in general anesthe-
sia were proposed in Silva et al. (2012), Silva et al. (2014b). These models have a parsimonious
structure containing a small number of patient-dependent parameters to describe the system. In
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Silva et al. (2012) a two-parameter single-input single-output (SISO) model for the induction neu-
romuscular blockade by means of rocuronium is proposed, and a four-parameter multiple-input
single-output (MISO) for the effect of propofol and remifentanil on the depth of anesthesia model
is proposed in Silva et al. (2014b). Recently, it was proven in Almeida et al. (2016) and Almeida
et al. (2017) that it is possible to design a positive control law using only the parameters associ-
ated to the nonlinear part of such models. These simplified models were the motivation for the
development of new algorithms to control the effect of the drugs during a general anesthesia to
be integrated in the Galeno platform. This platform was developed in the framework of the Por-
tuguese Science and Technology funding agency (FCT) project Galeno and incorporates several
identification and control procedures for automation in the administration of anesthetics.
1.1 Overview of general anesthesia
General anesthesia comprises three components: hypnosis, analgesia and muscle relaxation. To
achieve these goals, the anesthesiologists administer several drugs while simultaneously main-
taining all the vital functions, thus enabling a patient to undergo surgical procedures that would
otherwise be impossible or very painful to tolerate.
Muscle relaxation implies the loss of movement, which is essential for patient intubation, to
facilitate the access to internal organs, and to avoid movement responses as a result of surgical
stimuli. This is achieved by the administration of muscle relaxants that block the neuromuscular
activity. The NeuroMuscular Blockade (NMB) level is measured from an evoked muscle response
at the hand of the patient subject to electrical stimulation of the adductor pollicis muscle through
supra maximal train-of-four (TOF) stimulation of the ulnar nerve; it can be registered by elec-
tromyography (EMG), mecanomyography (MMG) or acceleromyography (AMG), Hemmerling
(2004), McGrath and Hunter (2006). The NMB level corresponds to the first single response (T1)
calibrated by a reference twitch, ranging between 100% (full muscular activity) and 0% (totally
paralysis).
Hypnosis is defined as the absence of consciousness and the inability of the patient to recall
intraoperative events. This is achieved by the administration of hypnotics and is measured by the
electroencephalographic activity. The electroencephalogram (EEG)-derived indices used to infer
the level of hypnosis of a patient are: the Spectral entropy (SE), Viertiö-Oja et al. (2004), the Index
of Consciousness (IoC), Jensen et al. (2008), and the Bispectral Index (BIS), Gan et al. (1997).
The most widely used index is the BIS. It is related to the responsiveness level and the probability
of recalling intraoperative events and it ranges from 97.7 (fully awake and alert state) to 0 (totally
absence of brain activity). During general anesthesia the adequate BIS level varies between 40
and 60.
Finally, analgesia is obtained by the administration of analgesics and allows the loss of the
pain. There is no single measure to analyze this condition; the anesthesiologists estimate the
analgesia level based on autonomic reactions, such that changes in blood pressure and heart rate,
1.2 Automatic drug delivery in anesthesia 3
sweating, pupil reactivity and the presence of tears, Guignard (2006). The hypnotics and anal-
gesics interact in such way that their effect is enhanced when administered together. The depth of
anesthesia (DoA) takes into account the combined levels of hypnosis and analgesia, and the BIS
is the index used to evaluate this feature.
The following figure shows the position of the sensors measure for the NMB and BIS, respec-
tively.
Figure 1.1: The left figure shows the sensor position to measure the NMB level, whereas the right
figure shows the place where the BIS sensor is set.
1.2 Automatic drug delivery in anesthesia
The development of automation techniques for anesthesia has been growing in last decade. The
use of an automatic system to monitor and control the drug administration during the surgery leads
to two benefits: the improvement of the global performance of the process in terms of safety, cost
reduction and patient comfort, and the possibility of releasing the anesthetist from some routine
tasks so that he/she can better concentrate on the state of the patient.
Figure 1.2 shows the feedback control scheme applied to drug delivery in anesthesia. In the
beginning the clinicians impose a desired reference effect and the control algorithms should com-
pute the adequate amount of drug(s) to achieve this set-point. If the measured effect does not
correspond to the desired one, the controller should automatically adapt the drug(s) dosage.
target error
Control algorithms
action Delivery
Devices
Sensors
effect
-
+
Clinical
supervisor
Figure 1.2: Automatic system for drug administration during general anesthesia.
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In the last decades, researchers have been improving the performance of the control algorithms
to be included in a system like the one in Figure 1.2. Regarding the control of the NMB level, the
initial studies on feedback control for the administration of muscle relaxants started around thirty
years ago, Brown et al. (1980), Jaklitsch and Westenskow (1987), Ritchie et al. (1985). A constant
gain Proportional-Integral-Derivative (PID) controller was developed in Lago et al. (1998). How-
ever the patient’s response variability is high and, to avoid this issue, methods for online tunning of
PID controllers to the individual patient dynamics were implemented Mendonça and Lago (1998),
Silva et al. (2005), Lago et al. (2000). An alternative method to tackle the high uncertainty in
neuromuscular blockade model is the use of multiple model switching control strategy as in Men-
donça et al. (2002), Neves et al. (2009) where a bank of suitable stabilising controllers, each of
them tuned for a different model, was used. More recently, the same strategy was considered but
using a different bank of controllers. This bank is constituted by positive controllers for feedback
stabilisation of positive compartmental systems that guarantee the convergence of the total system
mass to a set-point which, in turn, guarantees the tracking of a desired NMB level, Teixeira et al.
(2014).
With respect to the control of the depth of anesthesia, the first system to automatically achieve
a predefined individualized concentration of anesthetics in the plasma, and hence a desired drug
effect, was the target-controlled infusion (TCI), Glen (1998). Here the anesthesiologist sets the
desired theoretical (target) concentration of the drug, and the device calculates the amount of drug
to be administered in order to obtain specific concentration. The infusion rate is computed based
on population models for the PK/PD of the drugs. More concretely, the TCI devices incorporate
two models for the hypnotic propofol: the Marsh model, Marsh et al. (1991) and the Schnider
model, Schnider et al. (1998); and one model for the opioid remifentanil: the Minto model, Minto
et al. (1997). These models use information as the patient’s age, height, weight and gender. How-
ever, due to some inaccuracy in the patient’s dose-effect relationship that is not covered by the
linear PK/PD models, the anesthesiologists have an active role to adjust the suitable target effect
concentration for each patient, based on the monitored physiological signals. To overcome this
uncertainty, adaptive and predictive control strategies have been implemented to guarantee the
regulation of the closed-loop system subject to positivity constraints (on the drug dose dosage),
Chellaboina et al. (2006), Ionescu et al. (2008). Similar to what was done with the control of
the NMB, a PID controller was developed to compute an individualized hypnotic propofol dose
where the controller parameters were re-tuned based on the induced patient’s response, Soltesz
et al. (2011). The aforementioned controllers were meant for the automatic administration of the
hypnotic propofol; however as it was mentioned in Mendonça et al. (2006) and Labbaf et al. (2010)
that the opioid remifentanil has influence in the DoA. Focused on this influence, closed-loop con-
trollers were presented in Liu et al. (2011), Nogueira et al. (2014) to determine the amount of the
two drugs that should be administered to the patient in a combined way to achieve a desired BIS.
Alternative control schemes adopting optimal control techniques have been widely used in the
last years. The goal of optimal control is to find a control law for a given system such that a
certain optimality criterion (for instance, the minimization of a certain cost function) is achieved.
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An optimal control problem (OCP) usually involves a cost functional that is a function of the
state and the control variables. The optimal control solution has to satisfy the system dynamic
equations and to optimize the cost functional. Moreover, an OCP in general involves static con-
straints on the state and/or the control variables. The optimal control strategy can be derived
using Pontryagin’s Principle, Ross (2009), or by solving the Hamilton–Jacobi–Bellman equation,
Bellman (1957). However, determining the analytical optimal solution can be difficult or even
impossible to achieve. To overcome this issue, appropriate numeric solvers are used, see e.g.
Paiva (2013). In Almeida et al. (2017), Almeida et al. (2015a) and Almeida et al. (2015b), opti-
mal control theory was used to solve the problem of tracking a desired NMB or BIS level. This
has the advantage of enabling a penalty for the excessive use of drug. The corresponding OCPs
involve non-negativity constraints on the input and the state components, and are therefore hard
to solve. Goebel and Subbotin (2007) propose a technique based on duality for Linear Quadratic
Regulator (LQR) problems with constrained input, but assume that the origin is in the interior of
the allowable set for the control inputs, which is not the case for the NMB and BIS control sys-
tems. In Beauthier and Winkin (2010) LQ optimal control of positive linear systems is studied.
The optimal control is obtained through the solution of a Hamiltonian two point boundary value
problem and it is time dependent, i.e., it is an open-loop rather than a closed-loop (state feedback)
solution. Furthermore, for the continuous time example presented in the paper the solution has to
be obtained by numerical integration of the equations. A more recent paper on constrained LQR
problems, Burachik et al. (2014), proposes to solve the dual of the LQR problem but yields again a
controller that is time dependent and must be computed by a numerical algorithm. An alternative
technique for the control of positive linear systems yielding a state feedback controller is derived
in Roszak and Davison (2008), where a clamping controller with an integral term of the tracking
error is proposed. Although this is an extremely interesting technique leading to a state feedback
solution for positive linear systems, it does not correspond to the solution of an optimal control
problem. Furthermore, the integral term may suffer from the well known phenomenon of windup,
which should be avoided specially in the case of drug delivery, Almeida et al. (2017).
This thesis focuses on the feedback control of positive linear systems with a static nonlinearity
at the output in the context of anesthesia. The controllers presented in this thesis were design based
on simplified models, and consequently, present a simplified structure. More concretely, these
controllers only depend on the parameters associated to the static nonlinear part of the model. A
control law for positive systems is designed based on these simplified models and then compared
with controllers obtained by solving an optimal control problem.
The manuscript is organized as follows. Chapter 2 presents a brief overview of compartmental
systems together with the original and the simplified models used to design the control approaches.
The identification method used here, the Extended Kalman Filter, is presented in Chapter 3. In
Chapter 4 it is shown how the positive control law is designed for the NMB level and for the BIS
level and the corresponding simulation results are shown. Chapter 5 presents the design of the
state-feedback control using an optimal control problem formulated for the reference tracking of
the NMB level and of the BIS level, respectively. Some brief conclusions are drawn in Chapter 6.
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1.3 Thesis contributions
This thesis aims at giving further contributions to develop control schemes for drug administration
during general anesthesia. In this context two important components of anesthesia are considered:
the neuromuscular blockade (NMB) and the depth of anesthesia (DoA). The main contributions of
this thesis are the following:
1. In the case of the control of NMB level, the reduced model proposed in 2012, Silva et al.
(2012), involves two patient-dependent parameters, one in the linear part of the model and
another one for the nonlinear part. Here, we propose a simplification of this model to design
the controllers. More concretely, the control laws only have in consideration the parameter
associated with the nonlinear model. In the case of the BIS level, the model proposed in
Silva et al. (2014b) uses two patient-dependent parameters to describe the linear model and
another two to describe the nonlinear model. For this case, the simplified model proposed
here only takes into consideration the two patient-dependent parameters associated with the
nonlinear model.
2. Design of two positive control laws based on the simplified models mention in 1 to control
the NMB and the BIS level, respectively, as well as proof of the total system concentration
convergence to desired values and subsequent guarantee of tracking of the desired NMB and
BIS levels, respectively. The results obtained with these control laws are compared with the
infusion drug administered by the anesthesiologist, manually.
3. Formulation of two optimal control problems for the control of the NMB and the BIS level.
Due to the complexity associated with the existence of a positive constraint in the input the
OCP is relaxed into a semi-definite program (SDP) by replacing the original variables by
their moments up to a certain order. The optimal values of the moments are then computed
by a semi-definite programming solver.
4. Comparison of the performance of the control techniques in simulated patients to analyze
their incorporation in clinical environment, through the platform Galeno, Costa et al. (2014).
The control approaches mentioned above are applied in different databases.
2Compartmental models in anesthesia
In this chapter the models used to describe the relationship between the amount of administered
drug and the corresponding physiological effect are presented. These models are naturally or arti-
ficially endowed with a compartmental structure. First, PK/PD models are introduced. Although
they have a physiological meaning, they require a high number of patient-dependent parameters.
Therefore we next present the reduced parameter models introduced in Silva et al. (2012), Silva
et al. (2014b), which will be used in this thesis to design the control laws proposed in this thesis.
Moreover, it is shown that these reduced models have an artificial compartmental structure which
will be an important feature for the construction of controllers.
2.1 Compartmental models
Compartmental systems describe the transfer of matter between different compartments and play
therefore an important role in modeling physiological processes. In this section a brief overview
of such systems is presented.
xi
k0i
ui
kji
kij
Figure 2.1: A compartment of a compartmental system.
In figure 2.1, xi denotes the amount of relevant material in compartment i. The flow into
compartment i from outside the system is denoted by ui and is called inflow. Usually, ui is a
nonnegative function of time or just a nonnegative constant, but occasionally it may be dependent
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on the compartment mass x as well. The constants ki j ≥ 0 and k ji ≥ 0 represent the proportional
flows from compartment j into compartment i and from compartment i into compartment j, re-
spectively. Finally, k0i is the (proportional) outflow from compartment i to the environment. The
mass balance equations for every compartment can be written as ordinary differential equations
with the following form:
x˙i =
n
∑
j 6=i
−k jixi+ ki jx j +ui− k0ixi (2.1)
Considering the equation (2.1) for all compartments one obtains a state-space model as in
equation (2.2), which is a compartmental model in the sense of the following definition.
Definition 2.1 Linear compartmental system
A linear state-space system,
{
x˙(t) = Ax(t) +Bu(t),
y(t) =C x(t)+Du(t)
(2.2)
where x(t) ∈ Rn×1 is the state vector, u(t) ∈ Rp×1 is the input signal, y(t) ∈ Rq×1 is the output,
and A ∈ Rn×n, B = (bi j) ∈ Rn×p, C =
(
cl j
) ∈ Rq×n and D = (di j) ∈ Rq×p with n, p,q ∈ N are
the matrices of the system, is called compartmental if A ∈ Rn×n is a compartmental matrix (see
Definition 2.2 below) and moreover:
bi j ≥ 0 and cl j ≥ 0 ∀i = 1, . . . ,n; j = 1, . . . , p; l = 1, . . . ,q.
Definition 2.2 Compartmental matrix
The matrix A = (ai j) ∈ Rn×n is a compartmental matrix if:
1. A is a matrix with nonnegative off-diagonal entries, i.e., A is a Metzler matrix:
ai j ≥ 0, ∀ i, j ∈ {1, . . . ,n} and i 6= j
2. A is a matrix with nonpositive diagonal entries:
aii ≤ 0, ∀ i ∈ {1, . . . ,n}
3. A is diagonally dominant:
|aii| ≥ ∑ j 6=i a ji, ∀ i ∈ {1, . . . ,n}
Compartmental systems are a special class of positive systems. Therefore the sate and output
components are nonnegative provided that the initial state and the inputs are nonnegative.
Due to the high importance of compartmental models in the modeling of drug effects and to
the good performance of controllers based on these models, they will be the basis for the work
developed in this thesis.
The models presented in the next sections either possess by nature a compartmental structure
or can be "artificially" endowed with such a structure. This will be become clear in the sequel.
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Figure 2.2: Block diagram for the Wiener PK/PD model.
2.2 PK/PD compartmental based models for drug effect
This section presents the standard models used to characterize the dynamic effect of drugs ad-
ministered by continuous infusion on measured physiological variables, Meibohm and Derendorf
(1997). These models rely on the knowledge about mass transfer between compartments in the
human body and on the weights and volumes of such compartments. First, a linear pharmacoki-
netic (PK) model is used in order to explain the dynamic distribution of the administered drug
dose, u(t), through the different body compartments; this relates the model input u(t) in Figure
2.2 (administered drug dose) with the drug concentration in the blood cp(t). Then, a set of two
other blocks are connected in series with the first one, standing for the pharmacodynamics (PD),
i.e., in order to describe the relation between the plasmatic concentration, cp, and the drug effect,
y. More concretely, a linear differential equation relates the drug blood concentration cp(t) with its
effect concentration ce(t) while a nonlinear static equation, known as the Hill equation, relates the
effect concentration with the measured effect y(t). This PK/PD structure for the effect of infused
drugs constitutes a Wiener model: a linear dynamic part followed by a static nonlinear function,
Wigren (1993).
As already mentioned, the dynamic blocks are based on physiological mechanisms that are
well explained through compartmental models Godfrey (1983). The next sections present the
PK/PD compartmental based models for the NMB and BIS cases.
2.2.1 Model for atracurium - NMB case
Due to the physiological meaning of the PK/PD compartmental based model, the number of com-
partments varies according to the place in the human body where the drug is eliminated. For
instance, the model for the muscle relaxant atracurium only has three compartments because the
drug is spontaneously degraded whereas the model for the muscle relaxant rocuronium has four
compartments because the elimination of this drug is made by the liver, which corresponds to a
new compartment.
Figure 2.3 shows the PK/PD compartmental model that relates the administered dose of atracurium
with the effect concentration (corresponding to the first two blocks of the diagram in Figure 2.2).
The state-space model that translates the exchange of the concentration of mass between the com-
partments is:
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Figure 2.3: PK/PD compartmental model for the muscle relaxant atracurium. The central com-
partment is composed by the main organs heart, liver, lungs, kidney and by the blood, and the
peripheral compartment corresponds, for instance, to the fat tissue and the cerebrospinal fluid. In
this case the effect compartment corresponds to the muscle tissue.
x˙(t) =
−(k12+ k10+ k1e) k21
V2
V1
0
k12 V1V2 −(k21+ k20) 0
k1e V1V3 0 −ke0
 x(t) +

1
V1
0
0
u(t) (2.3)
ce(t) =
[
0 0 1
]
x(t)
where x(t) =
[
x1(t) x2(t) x3(t)
]T
is the time-varying mass concentration in each compartment,
u(t) is the infused drug dose and the constants k10, k12, k1e, ke0, k20, k21, which are patient depen-
dent parameters, represent the proportional flows among the compartments and the flows from the
compartments to the environment. V1, V2 and V3 correspond to the volumes of central compart-
ment, of the peripheral compartment, and of the effect compartment, respectively.
As already mentioned the effect concentration, ce(t), is related with the measured effect,
yPK/PDNMB (t), through the Hill equation,
yPK/PDNMB (t) =
100
1+
(
ce(t)
C50
)γ , (2.4)
where C50 and γ are patient dependent parameters, Weatherley et al. (1983).
Figure 2.4 shows the impulse effect concentration response (upper plot) and the impulse
NMB level response (bottom plot) to an initial bolus of 500µg.kg−1 of the simulated patient
number 98, which has the following parameter values: k10 = 0.1343min−1, k12 = 0.2337min−1,
k1e = 0.0028min−1, k20 = 0, k21 = 0.1296min−1, ke0 = 0.1064min−1, C50 = 0.6900µg.ml−1,
γ = 3.4982. The set of the PK/PD parameters are presented in Appendix A.
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Figure 2.4: Impulse effect concentration (upper plot) and the impulse NMB level (bottom plot) to
an initial bolus of 500µg.kg−1 of the muscle relaxant atracurium for the simulated patient number
98.
2.2.2 Model for remifentanil and propofol - BIS case
Similarly, to the muscle relaxant rocuronium, the hypnotic propofol and the analgesic remifentanil
are degraded in the liver, and consequently, their PK/PD compartmental model has four compart-
ments, Minto et al. (1997), Gepts et al. (1987). As it is possible to see in Figure 2.5, the drug is
administered in the main compartment with an infusion rate u(t) and the constants ke0, k10, k12,
k13, k21, k31 are the proportional flows among the compartments and the flows from the compart-
ments to the environment. These constants depend on the considering drug, and also vary from
patient to patient.
For each drug (propofol and remifentanil), the dynamic system that describes the exchange of
the mass concentration between the compartments is represented by a state-space model with the
following structure:
x˙(t) =

−(k10+ k12+ k13) k21 V2V1 k31
V3
V1
0
k12 V1V2 −k21 0 0
k13 V1V3 0 −k31 0
0 0 0 −ke0
x(t) +

1
V1
0
0
0
u(t)
ce(t) =
[
0 0 0 1
]
x(t) (2.5)
where Vi (ml) represents the volume of the compartment i. Here, compartments 1,2 and 3 corre-
spond to the central compartment, the peripheral compartment, and the effect compartment. In
clinical practice, the anesthesiologists use population models to infer the response of each patient
to a certain drug administration profile. For propofol, the parameters from Marsh’s model, Marsh
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Figure 2.5: PK/PD compartmental based model for both propofol and remifentanil.
et al. (1991), or from Schnider’s model, Schnider et al. (1998), are usually used, whereas for
remifentanil the parameters from Minto’s model, Minto et al. (1997) are used.
Both the propofol and the remifentanil effect concentrations, cPe (t) and c
R
e (t), respectively,
calculated from (D.1), are related with the measured effect, yPK/PDBIS (t), by a nonlinear equation.
First, cPe (t) and c
R
e (t) are normalized with respect to their concentration at half the maximal effect,
CP50 and C
R
50, respectively, as
UP(t) =
cPe (t)
CP50
, UR(t) =
cRe (t)
CR50
(2.6)
Due to the drug interaction, the joint effect of propofol and remifentanil is a function of the
potency of the drug mixture, which is defined as:
φ =
UP(t)
UR(t)+UP(t)
. (2.7)
The joint drug effect is computed by a generalized Hill equation as
y(t)PK/PDBIS = y0
1−
(
UP(t)+UR(t)
U50(φ)
)γ
1+
(
UP(t)+UR(t)
U50(φ)
)γ
 , (2.8)
where y0 is the BIS level at zero concentration, γ is a patient parameter, and U50(φ) is associated
with the half of the maximum effect of both drugs at ratio φ and is determined as
U50(φ) = 1−βφ +βφ 2 , (2.9)
where β is also a patient parameter.
Figure 2.6 shows the simulated BIS level response to a bolus (modeled as an impulse) of
propofol combined with a bolus (impulse) of remifentanil.
To simulate the impulse response for this PK/PD model, the parameters associated with the
linear model for propofol were obtained by Schnider’s model, whereas for remifentanil the param-
eters were obtained by Minto’s model (an explanation of how to obtain these parameter values is
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given in the Appendix D). More concretely, the values used in the simulation of the linear part are
the ones in Table 2.1.
Table 2.1: Values used to simulate the linear model of the PK/PD model both for propofol and
for remifentanil, corresponding to the Schnider model and the Minto model, respectively, for a 56
year-old female with 160cm of height and 88kg of weight.
Propofol Remifentanil
k10 (min−1) 0.6083 0.5106
k12 (min−1) 0.2853 0.3585
k13 (min−1) 0.1958 0.0132
k21 (min−1) 0.0687 0.1981
k31 (min−1) 0.0035 0.0107
ke0 (min−1) 0.4590 0.4830
V1 (ml) 4.2700 4.3745
V2 (ml) 17.7270 7.9165
V3 (ml) 238 5.4200
The values associated with the nonlinear Hill equation are: CP50 = 13.9395(mg.ml
−1), CR50 =
41.6474(mg.ml−1), β = 3.3266 and γ = 2.0321. These values were obtained using the hybrid
method for parameter estimation presented in Mendonça et al. (2012).
Figure 2.6: Simulated BIS level response to a bolus (modeled as an impulse) of propofol combined
with a bolus (impulse) of remifentanil.
2.3 Reduced parameter compartmental models for drug effect
This section presents compartmental models based on the reduced parameters models recently
proposed by Silva et al. (2012), Silva et al. (2014b). To characterize the dynamic effect of drugs
administered by continuous infusion on measured physiological variables. Similarly, to the PK/PD
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compartmental based model, these models have a Wiener structure and they relate the model
input u(t) (administered drug dose) with a standardized effect concentration by means of a linear
dynamics, while a nonlinear static equation relates the standardized effect concentration with the
measured effect y(t).
2.3.1 Model for atracurium - NMB case
In Silva et al. (2012) an alternative model was introduced to describe the relationship between the
administered drug dose of the muscle relaxant, atracurium, and the measured effect, which in this
case is the NMB level. This relationship is given by a SISO (Single Input, Single Output) Wiener
model, as illustrated in Figure 2.7.
u(t) k1k2k3 α
3
(s+ k1α)(s+ k2α)(s+ k3α)
ce(t) 100
1+
(
ce(t)
C50
)γ yRMNMB(t)
Figure 2.7: Block diagram that relates the drug dose of muscle relaxant, u(t), with the NMB
response, yNMB(t), according Silva et al. (2012).
The administered drug dose of the muscle relaxant is related with the standardized drug con-
centration in the effect compartment by the following third-order linear dynamical model:
Ce(s) = H(s)U(s), (2.10)
with
H(s) =
k1 k2 k3α3
(s+ k1α)(s+ k2α)(s+ k3α)
, (2.11)
and where Ce(s) is the Laplace transform of the output of the linear of model, ce(t)(µg.ml−1),
that corresponds to the standardized effect concentration, and the U(s) is the Laplace transform
of the input signal, u(t)(µg.kg−1 .min−1), consisting of the muscular relaxant dose. Moreover,
k1 < k2 < k3 are positive constants which are fixed to be equal to 1, 4 and 10, respectively, and
α > 0 is a patient-dependent parameter.
Note that the transfer function H(s) has three negative real poles namely, s1 = −k1α , s2 =
−k2α and s3 =−k3α , and is therefore BIBO (Bounded-Input, Bounded-Output) stable (see Defi-
nition 2.2.1. in Kisacanin and Agarwal (2001)).
Moreover, since lims→0 H(s) =H(0) = k1k2k3α
3
k1αk2αk3α = 1, the unit step response set point is given
by lims→0 sH(s) 1s = H(0) = 1, see, e.g., Bourlés (2013), meaning that, the transfer function H(s)
has unitary static gain. Note that the static gain of the linear part of the PK/PD model presented in
Section 2.3.1 is in general not equal to 1. This explains why ce is regarded as standardized effect
concentration rather than an approximation of the actual effect concentration.
This new model replaces the linear part of the PK/PD model presented in Section 2.2.1 by
means of the transfer function H(s), which has a parsimonious structure, in the sense that the
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patient’s response is represented by a small number of parameters. More concretely, here there
is only one patient-dependent parameter α instead of the six parameters of the linear PK/PD
model. This model has great advantages from the point of view of parameter identification and
implementation of online controllers.
The transfer function H(s) can be realized by the following state-space model,{
x˙(t) = αAx(t) + αBu(t)
ce(t) =
[
0 0 1
]
x(t) ,
(2.12)
where x(t) =
[
x1 x2 x3
]T
is the state vector and the matrices A and the vector B are defined as
A =
−k3 0 0k2 −k2 0
0 k1 −k1
 and B =
k30
0
 .
Note that the state component x3(t) corresponds to the effect concentration. Although this model
does not have a physiological meaning, it can be seen as a compartmental model similar to the one
presented in Figure 2.3 (Section 2.2.1). Figure 2.8 shows this artificial compartmental structure.
k3αu(t) Compartment 1
k3α
k2α Compartment 2
k2α
k1α
Compartment 3
k1α
Figure 2.8: Diagram block that represents the artificial compartmental structure of the state-space
realization (2.12) of the reduced model for the NMB response to atracurium.
As shown in Figure 2.7, the effect concentration is related with the patient NMB level through
the following nonlinear static equation, known as Hill equation, Weatherley et al. (1983),
yRMNMB(t) =
y0
1+
(
ce(t)
C50
)γ , (2.13)
where C50 denotes the effect concentration at half of the maximal effect, and is taken to be fixed
at the value 3.2435, y0 is equal to the maximum value of yNMB, which is 100% and γ is a patient-
dependent parameter.
The overall model only has two parameters (α and γ) to be identified for each patient, in
contrast with the eight of the PK/PD model presented in Section 2.2.1 and is therefore referred to
as reduced model.
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Figure 2.9 shows the impulse standardized effect concentration and the impulse NMB response
to an initial bolus of 500µg.kg−1 of atracurium when the patient number 98 of the database is
modeled by the reduced model. The patient parameters are: α = 0.0425 and γ = 4.020. The set
of the parameters for this model are presented in Appendix B.
Figure 2.9: Impulse standardized effect concentration (upper plot) and impulse NMB response
(bottom plot) to an initial bolus of 500µg.kg−1 of atracurium for the simulated patient number 98.
Figure 2.10 shows the comparison between the NMB response obtained by the two models for
a patient simulated with the mean values of the parameters of the database. As it is possible to see,
the reduced model approximates well the NMB response of the PK/PD model.
Figure 2.10: NMB impulse responses obtained through the reduced model (red line) and through
the PK/PD model (blue line).
The complete reduced model is a good approximation to the PK/PD model. This together with
other published results, Silva et al. (2014a), has motivated its use in this thesis for the construction
of some automatic control schemes.
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2.3.2 Model for remifentanil and propofol - BIS case
Similar to the NMB case, a reduced Wiener model was proposed in Silva et al. (2014b) for the
description of the joint effect of propofol and remifentanil on the BIS level. This model consists
of two linear parts, one for the relationship between the propofol dose and its standardized effect
concentration and another one for the standardized effect concentration of remifentanil, followed
by static nonlinear equation, as shown in Figure 2.11.
uR(t)
d1d2d3 ξ
3
(s+ d1ξ)(s+ d2ξ)(s+ d3ξ)
cRe (t)
uP (t)
l1l2l3 η
3
(s+ l1η)(s+ l2η)(s+ l3η)
cPe (t)
y0
1+(z(t))γ
yRMBIS(t)
Figure 2.11: Block diagram that relates the drug doses of the propofol, uR(t), and remifentanil,
uP, with the BIS level, yBIS(t), according to Silva et al. (2014b).
Each individual linear model is similar to the one presented in the previous section for the NMB
level and has therefore the same properties.
The linear dynamics of the propofol model is given by the transfer function
HP(s) =
CPe (s)
UP(s)
=
d1 d2 d3 ξ 3
(s+d1ξ )(s+d2ξ )(s+d3ξ )
, (2.14)
and the linear model for the effect concentration of remifentanil is similarly given by
HR(s) =
CRe (s)
UR(s)
=
l1 l2 l3η3
(s+ l1η)(s+ l2η)(s+ l3η)
, (2.15)
where CPe (s) and C
R
e (s) are the Laplace transforms of the standardized effect concentrations of
propofol and remifentanil, cPe (t)(mg.ml
−1) and cRe (t)(mg.ml−1), respectively; UP(s) and UR(s)
are the Laplace transforms of the input doses of propofol and remifentanil, uP(t)(mg.min−1) and
uR(t)(mg.min−1), respectively.
Again, d1 , d2 , d3 and l1 , l2 , l3 have fixed values that have been suitably determined in Silva
et al. (2014b); d1 , d2 , d3 are equal to 1, 9 and 10, respectively, and l1 , l2 , l3 are equal to 1, 2 and
3, respectively; ξ and η are the patient dependent parameters.
This reduced model replaces the linear part of the PK/PD model for both the hypnotic and
the analgesic model through the transfer functions HP(s) and HR(s), respectively, with a minimal
number of parameters to represent the patient’s response.
A state-space representation for the linear part of the hypnotic model is given by:
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 x˙
P(t) = ξAPxP(t) + ξBPuP(t)
cPe (t) =
[
0 0 1
]
xP(t) ,
(2.16)
where the matrix AP and the vector BP are defined as
AP =
−d3 0 0d2 −d2 0
0 d1 −d1
 and BP =
d30
0
 . (2.17)
Similarly, a state-space representation for the linear part of the analgesic model is x˙
R(t) = ηARxR(t) + ηBRuR(t)
cRe (t) =
[
0 0 1
]
xR(t)
(2.18)
where the matrix AR and the vector BR are defined as
AR =
−l3 0 0l2 −l2 0
0 l1 −l1
 and BR =
l30
0
 . (2.19)
Similarly, to the NMB model, the reduced model for the depth of anesthesia does not have a
physiological meaning and a natural compartmental structure; however it is possible represent it
as two artificial compartmental models (one for propofol and another one for remifentanil), where
each one has a block diagram structure as depicted in Figure 2.8, with the obvious adaptations for
the proportional flows values.
The nonlinear static equation proposed in Silva et al. (2014b) to describe the drug interaction
and the relation between the effect concentration and the drug effect, the BIS level, is given by
yRMBIS(t) =
y0
1+ z(t)ζ
, (2.20)
with z(t) = mUP(t) +UR(t) , UP(t) = c
P
e (t)
CP50
and UR(t) = c
R
e (t)
CR50
; m and ζ are patient-dependent pa-
rameters and CP50 and C
R
50 have fixed values for all patients, namely 10mg.ml
−1 and 0.1mg.ml−1,
respectively, y0 is equal to 97.7 which corresponds to the maximum value of yRMBIS(t). This can
be viewed as a simplified Hill equation. Thus, the BIS model has as parameter vector θ =[
ξ η m ζ
]T
. Figure 2.12 shows the impulse response of the BIS level for patient 1 in the
BIS database when propofol and remifentanil are administered as hypnotic and analgesic, re-
spectively, both for the PK/PD model and for the reduced model. The values of the parame-
ters used to simulate this patient’s response can be found in Appendix D and in Appendix E,
respectively, and are equal to V1 = 4.27, V2 = 17.73, V3 = 238, k10 = 0.6081, k12 = 0.2853,
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k13 = 0.196, k21 = 0.0687, k31 = 0.0035 and ke0 = 0.456 for the propofol PK/PD model and are
equal to V1 = 4.37, V2 = 7.91, V3 = 5.42, k10 = 0.5106, k12 = 0.3585, k13 = 0.0132, k21 = 0.1981,
k31 = 0.0107 and ke0 = 0.483, for the remifentanil PK/PD model, and equal to ξ = 0.0667,
η = 0.3989, m = 2.1502 and ζ = 1.7695, for the reduced model.
Figure 2.12: Impulse responses of the BIS level when propofol and remifentanil are administered
as hypnotic and analgesic, respectively, obtained with the reduced model (red line) and with the
PK/PD model (blue line).
In this chapter, the definition of compartmental systems was introduced and it was proved that
the reduced parameter models can be viewed as compartmental systems as they allow compart-
mental state space realizations. Furthermore, comparisons between the PK/PD models and the
reduced parameter models, for the NMB and BIS level, were performed. The similarity of the
impulse responses obtained for the two types of models justifies the used of the reduced parameter
models in the controller design.
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3System Identification
This chapter presents the method used to identify the patient parameters, namely the Extended
Kalman Filter. This method is applied to the NMB model and to the BIS model.
3.1 Introduction
In 1960, Rudolph E. Kalman published a paper, Kalman (1960), where a recursive method to
obtain an estimate of the solution of a discrete-time linear system was proposed, which became
known as the Kalman Filter (KF). With the inscrease of the digital computation, the Kalman filter
has been widely used in system identification. This filter produces and estimate of the state of
a system from a set of observations by minimizing the mean observed squared error, Welch and
Bishop (1995).
The Extended Kalman Filter (EKF) is the version of the Kalman filter for nonlinear systems,
but it can also be used to estimate model parameters by considering such parameters as extra
state components. This will be explained in this thesis in order to identify the patient-dependent
parameters for the NMB and BIS models.
Let us consider the following nonlinear discrete time system:{
xd(k+1) = f
(
k, xd(k), ud(k)
)
+ g
(
k, xd(k)
)
w(k)
yd(k) = h
(
k, xd(k)
)
+ e(k) ,
(3.1)
where xd(k) ∈ ℜn×1 is the state vector, ud(k) ∈ ℜp×1 the vector of inputs and yd(k) ∈ ℜq×1 the
vector of system output; w(t) and e(t) are the process noise and the observation noise, both of
which are white and gaussian and have covariance matrices R1(t) and R2(t), respectively. The
EKF allows an individualized adjustment of the states based on the evolution of the covariance
matrices of the state estimate.
The algorithm of the EKF for continuous-time systems can be summarized in the following
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equations, Söderström (2002):
H(k) =
∂h(k,xd)
∂xd
∣∣∣∣
xd=xˆd(k|k−1)
K(k) = P(k|k−1)HT (k)
×[H(k)P(k|k−1)HT (k)+R2(k)]−1
xˆd(k|k) = xˆd(k|k−1)+K(k)[yd(k)−h(k, xˆd(k|k−1))]
P(k|k) = P(k|k−1)−K(k)H(k)P(k|k−1) (3.2)
xˆd(k+1|k) = f (k, xˆd(k|k),ud(k))
F(k) =
∂ f (k,xd)
∂xd
∣∣∣∣
xd=xˆd(k|k)
G(k) = g(k,xd)
∣∣
xd=xˆd(k|k)
P(k+1|k) = F(k)P(k|k)FT (k)+G(k)R1(k)GT (k),
where K(k) is the Kalman gain at the instant k, xˆd(k|k) is the a priori state estimate, P(k|k) is the
corresponding covariance matrix, xˆd(k+1|k) is the a posteriori state estimate and P(k+1|k) is its
covariance matrix.
The next two sections present the application of the EKF to the NMB model and to the BIS
model in order to identify their patient-dependent parameters.
3.2 NMB model identification
In order to apply the EKF, the NMB model (2.12), with parameters α and γ , is first discretized
using the zero-order hold (zoh) method, see, e.g., Chen (1998), yielding:{
xd(k+1) = Φ(α)xd(k) + Γ(α)ud(k)
cde (k) = C x
d(k) ,
(3.3)
where {
Φ(α) = eA(α)h
Γ(α) =
∫ h
0 e
A(α)s dsB(α) ,
h is the (fixed) sampling time, for a given continuous time function r(·), rd(k) = r(kh), k =
0,1,2, . . ., xd ∈ ℜ3×1 is the discrete state, cde ∈ ℜ is the output of the system (effect concentra-
tion of the drug) and the matrices Φ(α) ∈ ℜ3×3 and Γ(α) ∈ ℜ3×1 are the counterparts of the
matrices A(α) and B(α) in the discretized system. Note that, the zoh discretization method is
only exact if the input is constant in each sampling interval, Chen (1998). In the NMB case, this
sampling interval usually pasts 20 seconds.
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As mentioned before, the static nonlinear part of the NMB model is described by the Hill
equation,
ydNMB(k) =
100
1 +
(
cde (k)
C50
)γ = 100
1 +
(
C xd(k)
C50
)γ . (3.4)
In addition to the state identification, xd1(k), x
d
2(k) and x
d
3(k), the EKF allows to identify the pa-
rameters of the model, α and γ , by introducing them as components of an extended state, defined
as:
xd(k) =

xd1(k)
xd2(k)
xd3(k)
xd4(k)
xd5(k)
=

xd1(k)
xd2(k)
xd3(k)
αd(k)
γd(k)
 , (3.5)
whereas the dynamics of the first three components is given by (3.3), the evolution of the last two
components, corresponding to the parameters is given by:{
αd(k+1) = αd(k)
γd(k+1) = γd(k)
(3.6)
as the true values of the parameters are fixed.
The model for the extended state vector, obtained by combining (3.3), (3.5) and (3.6), is as
follows:
xd(k+1) =
(
Φ
(
αd(k)
)
0(3×2)
0(2×3) I(2×2)
) x
d(k)
αd(k)
γd(k)
+(Γ(αd(k))
0(2×1)
)
ud(k)+
wx(k)wα(k)
wγ(k)

≡

f1(k,xd(k),ud(k))
f2(k,xd(k),ud(k))
...
f5(k,xd(k),ud(k))
+w(k)
≡ f (k,xd(k),ud(k))+w(k) (3.7)
ydNMB(k) =
100
1+
(
Cxd(k)
C50
)xd4(k)
≡ h(k,xd(k))+ e(k) (3.8)
C = (C 0 0) . (3.9)
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In order to apply the EKF algorithm it is necessary to compute the Jacobian matrices F and H
for the functions f (k,xd ,ud) and h(k,xd), respectively. Here F is computed analytically as:
F(k) =

∂ f1(k,xd(k),ud(k))
∂xd1(k)
∂ f1(k,xd(k),ud(k))
∂xd2(k)
. . . ∂ f1(k,x
d(k),ud(k))
∂xd5(k)
...
...
...
∂ f5(k,xd(k),ud(k))
∂xd1(k)
∂ f5(k,xd(k),ud(k))
∂xd2(k)
. . . ∂ f5(k,x
d(k),ud(k))
∂xd5(k)
 , (3.10)
whereas the H is obtained numerically, similar to what was done in Silva et al. (2012), as:
H(k) =
∂h(k,xd(k))
∂xd(k)
(3.11)
=
h(k,xd(k)+∆xd(k))−h(k,xd(k))
∆xd(k)
,
∆xd(k) represents the step of differentiation. Here, the step ∆xd(k) = 1×10−5 was chosen.
The initial guess of the vector xˆd(k|k−1) influences the velocity of the estimate convergence
towards the right values of the parameters. Here, and according to the values chosen in Silva et al.
(2012), the initial guess is taken to be:
xˆd(0|−1) = (0.000 0.000 0.000 0.030 1.000)T . (3.12)
The initial guess for the convariance matrix P(k|k−1) was based on an empirical analysis taking
into account the used database, Silva et al. (2012):
P(0|−1) = diag
(
10 100 10−1 10−3 10−2
)
. (3.13)
In a similar way the covariance matrices R1 e R2 are obtained as
R1 = diag
(
10−1 10−1 10−1 10−6 10−3
)
(3.14)
R2 = 10−1 . (3.15)
To analyze the performance of the identification method, simulations were carried out using
real NMB signals collected from patients submitted to general anesthesia. Figures 3.1 and 3.2
show the patient response and the model parameters, respectively, identified by the EKF when the
previous initial state and matrices are used.
As it is possible to see in Figure 3.1, the estimated signal obtained by the EKF reflects the
behavior of the real signal.
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Figure 3.1: NMB level estimated by the EKF (blue line) and the one collected during a general
anesthesia (red dashed line).
Figure 3.2: Parameter estimation performed by the EKF.
3.3 BIS model identification
Similarly to what was done to identify the parameters for the NMB model, this section presents
the discrete time model used to apply the EKF for the identification of the parameters of the BIS
model.
The discrete time BIS model for a sampling time h can be represented as follows.
xd(k+1) = Φ(ξ ,η)xd(k) + Γ(ξ ,η)ud(k)
zd(k) = C (m) xd(k)
ydBIS (k) =
y0
1+(zd(k))ζ
,
(3.16)
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with {
Φ(ξ ,η) = eA(ξ ,η)h
Γ(ξ ,η) =
∫ h
0 e
A(ξ ,η)s ds B(ξ ,η) ,
where the notation is similar to the one of the previous section. Moreover ud ∈ℜ2×1 represents the
drug dose infusion for propofol (first component) and remifentanil (second component), xd ∈ℜ6×1
is the discrete state, zd ∈ℜ is the joint effect concentration resulting from the interaction between
propofol and remifentanil and the matrices Φ(ξ ,η) ∈ ℜ6×6 and Γ(ξ ,η) ∈ ℜ6×2 are the discrete
counterparts of the matrices A(ξ ,η) and B(ξ ,η). The output of the model is ydBIS. Note that, for
the BIS level, h is usually taken to be equal to 5 seconds.
As in the NMB model, in addition to the estimation of the state components, xd1(k), x
d
2(k),
xd3(k), x
d
4(k), x
d
5(k) and x
d
6(k), the EKF is used to identify the parameters, ξ , η , m and ζ , of the
model joining them to the state to obtain an extended state vector:
xd(k) =

xd1(k)
xd2(k)
...
xd6(k)
xd7(k)
xd8(k)
xd9(k)
xd10(k)

=

xd1(k)
xd2(k)
...
xd6(k)
ξ d(k)
ηd(k)
md(k)
ζ d(k)

, (3.17)
The model for estimation of the extended state vector is obtained as in the NMB case, yielding:
xd(k+1) =
(
Φ
(
ξ d ,ηd
)
0(6×4)
0(4×6) I(4×4)
)(
xd(k)
θ p (k)
)
+
(
Γ
(
ξ d ,ηd
)
0(4×2)
)
ud(k)+w(k)
≡

f1(k,xd(k),ud(k))
f2(k,xd(k),ud(k))
...
f10(k,xd(k),ud(k))
+w(k)
≡ f (k,xd(k),ud(k))+w(k) (3.18)
ydBIS(k) =
y0
1+
(
C(θ)xd(k)
)xd10(k)
≡ h(k,xd(k))+ e(k) (3.19)
C(θ) =
(
C(θ) 0 0 0 0
)
. (3.20)
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The linearization of the function f (k,x) was performed analytically as,
F(k) =

∂ f1(k,xd(k),ud(k))
∂xd1(k)
∂ f1(k,xd(k),ud(k))
∂xd2(k)
. . . ∂ f1(k,x
d(k),ud(k))
∂xd10(k)
...
...
...
∂ f10(k,xd(k),ud(k))
∂xd1(k)
∂ f10(k,xd(k),ud(k))
∂xd2(k)
. . . ∂ f10(k,x
d(k),ud(k))
∂xd10(k)
 (3.21)
and the linearization of the function h(k,xd) was performed numerically as in equation (3.12) with
∆xd(k) = 1×10−13. The initial guess of the vector xˆd(k|k−1) corresponds to the minimal values
for the states and for the parameters,
xˆd(0|−1) =
(
0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2 1
)T
, (3.22)
and the initial guess for the covariance matrix P(k|k−1) was based on an empirical analyze taking
into account the used database.
P(0|−1) = diag
(
105 104 10 105 104 10 102 102 102 102
)
, (3.23)
In a similar way the covariance matrices R1 e R2 are obtained as,
R1 = diag
(
106 105 102 106 105 102 103 103 103 103
)
,
R2 = 1×1013 (3.24)
To analyze the performance of the identification method, simulations were carried out using real
BIS signals collect from patients submitted to general anesthesia when both propofol and remifen-
tanil were administered. More concretely, the response corresponds to the patient number 1 of the
database presented in Appendix D. Figures 3.3 and 3.4, respectively, show the patient response
and the model parameters, respectively, estimated by the EKF.
Figure 3.3: BIS level estimated by the EKF (blue line) and the one collected during a general an
anesthesia (red dashed line).
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Figure 3.4: Parameter estimation performed by the EKF for the BIS model.
Figure 3.3 shows that the EKF estimates still capture the behavior of the BIS signal, even
though the noise level is higher in this signal than in the NMB case. Due to the good results
achieved with the EKF, in this thesis the model parameters needed for controller design will be
identified using this method.
The results obtained in this section show that the response corresponding to the identified
parameters reflects well the behavior of the real signal, even in the presence of a noise, as it is
possible to see in the BIS case.
4Simplified control applied in general
anesthesia
In Bastin and Provost (2010) a positive control law for compartmental systems was proposed for
the stabilization of the total system mass (i.e., of the sum of the mas of the relevant material present
in each system compartment). Although in the applications considered in this thesis concentra-
tions, rather than masses, are used, a similar law can be applied to control the NMB level and the
BIS level.
The original positive control law will be presented in this chapter for each model considered
in Chapter 2. Moreover, a simplification of this law will be proposed to be applied in the adminis-
tration of specific drugs during a general anesthesia. This simplified control scheme only requires
the knowledge of half of the patient dependent parameters for the NMB model and for the BIS
model.
At the end of the chapter, the control resulting from the combination of the simplified control
law with the parameter identification is presented and applied to the databases for the NMB level
and BIS level. The performance of the control scheme is analyzed using a cost functional that
penalizes both the tracking error and the total amount of administered drug.
4.1 Positive control law
The control law presented in this section is the one introduced in Bastin and Provost (2010),
originally designed as a positive control law for feedback stabilization of the total system mass in
compartmental dynamical systems.
Recall the notion of compartemental system introduced in Def. 2.1
If xi stands for the mass of the relevant material contained in compartment i, the total system
mass, M(x), for a system with n compartments is defined as:
M (x(t)) =
n
∑
i=1
xi(t) =
[
1 . . . 1
]
x(t). (4.1)
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The dynamics of M (x(t)) can be obtained from the compartmental system equations. Indeed,
consider the following representation:{
x˙(t) = Ax(t) +Bu(t)
y(t) =C x(t) ,
(4.2)
of a continuous single-input/single-output 1 compartmental system where x(t) ∈ Rn is the state
vector, u(t)∈R is the input signal, and A∈Rn×n, B∈Rn×1 and C ∈R1×n are the system matrices.
From the equation (4.1) and (4.2) we obtain:[
1 . . . 1
]
x˙(t) =
[
1 . . . 1
]
Ax(t) +
[
1 . . . 1
]
Bu˜(t)
⇔
.︷ ︸︸ ︷
M (x(t)) =
[
1 . . . 1
]
Ax(t) +
[
1 . . . 1
]
Bu˜(t) , (4.3)
where
.︷ ︸︸ ︷
M (x(t)) = dM(x)dt .
In order to stabilize M (x(t)) at a given set point M∗ ≥ 0, the idea is to first determine u(t) =
u˜(t) such that,
.︷ ︸︸ ︷
M (x(t)) =−λ (M(x(t))−M∗) , (4.4)
where λ is a positive arbitrary design parameter and M∗ is the desired system mass. From equation
(4.4) one obtains,
.︷ ︸︸ ︷
M (x(t)) =
.︷ ︸︸ ︷
M (x(t))−M∗ =−λ (M(x(t))−M∗) . (4.5)
Setting ∆M = M (x(t))−M∗, equation (4.5) becomes,
.︷︸︸︷
∆M =−λ∆M. (4.6)
Since −λ < 0, the system (4.6) is asymptotically stable, i.e.,
lim
t→+∞(M (x(t))−M
∗) = 0, (4.7)
or, equivalently,
lim
t→+∞M (x(t)) = M
∗, (4.8)
1This is the case of interest for our application
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Taking into account the equations (4.3) and (4.4):[
1 . . . 1
]
Ax(t)+
[
1 . . . 1
]
Bu˜(t) =−λ (M (x(t))−M∗) (4.9)
⇔ u˜(t) =
(
n
∑
i=1
bi
)−1(
−λ (M (x(t))−M∗)−
[
1 . . . 1
]
Ax(t)
)
⇔ u˜(t) =−
(
n
∑
i=1
bi
)−1([
1 . . . 1
]
Ax(t)+λ (M (x(t))−M∗)
)
, (4.10)
where bi are the entries of the column matrix B of equation (4.2). In a second stage, in order to
force its positivity, the input signal u(t) is defined as:
u(t) = max(0, u˜(t)) (4.11)
The control law for the tracking of a desired reference level M∗ for the total system mass is
then given by: 
u(t) = max(0, u˜(t))
u˜(t) =−
(
n
∑
i=1
bi
)−1([
1 . . . 1
]
Ax(t)+λ (M (x(t))−M∗)
) (4.12)
The following theorem guarantees the convergence of the state trajectories of the closed-loop
system (4.2)-(4.12) to the setΩM∗ =
{
x ∈ℜ3 : M (x) = M∗}, known as the iso-mass corresponding
to the value M∗.
Theorem 4.1.1 For the closed-loop system (4.2)-(4.12) with arbitrary initial condition x(0) ≥ 0
(i.e., with nonnegative components)
• the iso-mass ΩM∗ is forward invariant;
• the state vector x(t) is bounded for all t > 0 and converges to the iso-mass ΩM∗ .
The proof of this theorem is given in Almeida (2010).
The idea now is to use the mass control in order to achieve the control of a desired physio-
logical effect. More concretely, it turns out that the control law (4.12) of a system (4.2) not only
drives the system mass to a value M∗, but it also drives the system to a steady-state in the iso-mass
ΩM∗ and consequently to a certain value of the output of the linear model (4.2), Almeida (2010).
Therefore, by a suitable choice of the value M∗, one can obtain the desired steady-state value for
y(t), and consequently drive the desired physiological effect to a desired reference value.
4.1.1 Control for atracurium - NMB case
In this section the positive control law is applied to the NMB case to control the dose of muscle
relaxant to be administered during a general anesthesia.
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The control law is designed based on the reduced compartmental model presented in the pre-
vious chapter. Recall that, the effect concentration is obtained by the following state-space model
x˙(t) = α
−k3 0 0k2 −k2 0
0 k1 −k1

︸ ︷︷ ︸
A
x(t)+α
k30
0

︸ ︷︷ ︸
B
u(t)
ce(t) =
[
0 0 1
]
︸ ︷︷ ︸
C
x(t) ,
(4.13)
with k1 = 1, k2 and k3 = 10.
The neuromuscular blockade level is given by the Hill equation,
yNMB(t) =
100
1+
(
ce(t)
C50
)γ . (4.14)
The control law is obtained by substituting these matrices in the control law (4.12),
u(t) = max(0, u˜(t))
u˜(t) =− 1
k3
(
(k2− k3)x1(t)+(k1− k2)x2(t)− k1x3(t)
)
− 1
k3α
λ
(
M(x(t))−M∗
)
u˜(t) =− 1
10
(
−6x1(t)−3x2(t)− x3(t)
)
− λ
10α
(
M(x(t))−M∗
)
.
(4.15)
As mentioned before, a suitable choice of the value of M∗ drives the desired NMB level to a
desired reference value yre fNMB. For this purpose, the equilibrium point x
e of the closed-loop system
(4.13)-(4.15) when M (x(t)) = M∗ is computed through the following system,{
A˜xe(t) = 0
M (xe) = M∗ .
(4.16)
where A˜=A−α
10
0
[−6 −3 −1] is the closed-loop matrix for M (x) =M∗, and consequently
u(t) = u˜(t) =− 110
(
−6x1(t)−3x2(t)− x3(t)
)
.
The obtained result is the vector,
xe =
[
M∗
3
M∗
3
M∗
3
]
. (4.17)
Moreover, it can be shown that this equilibrium point is asymptotically stable with respect to the
dynamics of the closed-loop system restricted to the iso-mass ΩM∗ , Almeida (2010). Therefore,
setting
M∗ = 3xe3 = 3c
re f
e (γ) , (4.18)
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where cre fe (γ) is calculated by the inversion of the Hill equation (4.14),
cre fe (γ) =
(
100
yre fNMB
−1
)1/γ
C50 , (4.19)
yields a control law that tracks the desired NMB reference level yre fNMB. This level is usually taken
as 10% in the clinical practice for general anesthesia.
Figure 4.1 shows the NMB level evolution when the drug dose is determined by the controller
presented above. As it is possible to see M (x(t)) converges to the desired system mass M∗ and,
consequently, the NMB level achieves the desired value of 10%. The controller was designed
using the parameters of the model 17 of Appendix B. Using these parameters, α17 = 0.0366,
γ17 = 1.9262, and equations (4.18) and (4.19) the value of M∗ is equal to 30.4458µg.ml−1. At
the initial time, a typical bolus of 500µg.kg−1 of atracurium is administered and the controller
actions begins after a certain time t∗. This instant time is computed by an algorithm proposed
by Silva et al. (2009) called On Line tuned Algorithm for Recovery Detection (OLARD). This
algorithm determines the instant when the patient begins to recover from the initial bolus. The
design parameter λ was chosen empirically and taken equal to 0.2.
Figure 4.1: NMB level evolution when the drug dose is determined by the positive control law.
The star represents the time instant when the controller action begins.
Figure 4.2 shows the NMB level for the hundred models presented in Appendix B and the
average NMB level response for these cases, y¯NMB. As expected all cases achieve the desired
NMB level despite the variability presented in the upper plot.
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Figure 4.2: The upper plot presents the NMB level evolution when the drug dose is determined by
the positive control law for the hundred models and the bottom plot presents the average response
signal of these hundred models.
4.1.2 Control of remifentanil and propofol - BIS case
In the same line of what has been done in the previous subsection, this section presents one control
law for the hypnotic, propofol, and another one for the analgesic, remifentanil, in order to achieve
a desired BIS level. Since, the models are very similar, the control laws will be similar too.
As shown in the previous chapter, the models for the effect concentration of propofol and of
remifentanil are represented by the following state-space realizations, respectively,
x˙P(t) = ξ
−d3 0 0d2 −d2 0
0 d1 −d1

︸ ︷︷ ︸
AP
xP(t)+ξ
d30
0

︸ ︷︷ ︸
BP
uP(t)
cPe (t) =
[
0 0 1
]
xP(t) ,
(4.20)

x˙R(t) = η
−l3 0 0l2 −l2 0
0 l1 −l1

︸ ︷︷ ︸
AR
xR(t)+η
l30
0

︸ ︷︷ ︸
BR
uR(t)
cRe (t) =
[
0 0 1
]
xR(t) ,
(4.21)
with d1 = 1, d2 = 9, d3 = 10, l1 = 1, l2 = 2 and l3 = 3.
The bispectral index is related with each effect concentrations, cPe (t) and c
R
e (t) by the Hill equation,
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yBIS(t) =
97.7
1+ z(t)ζ
, (4.22)
where z(t) = m c
P
e (t)
CP50
+ c
R
e (t)
CR50
. Note that, CP50 and C
R
50 have fixed values, namely C
P
50 = 10mg.ml
−1
and CR50 = 0.1mg.ml
−1.
Substituting the model matrices in the control law (4.12), the following control laws for the
propofol and remifentanil, are obtained, respectively,
uP(t) = max
(
0, u˜P(t)
)
u˜P(t) =− 1
d3
(
(d2−d3)xP1 (t)+(d1−d2)xP2 (t)−d1xP3 (t)
)
− 1
d3ξ
λP
(
M(xP(t))−M∗P
)
u˜P(t) =− 1
10
(
−xP1 (t)−8xP2 (t)− xP3 (t)
)
− 1
10ξ
λP
(
M(xP(t))−M∗P
)
(4.23)

uR(t) = max
(
0, u˜R(t)
)
u˜R(t) =− 1
l3
(
(l2− l3)xR1 (t)+(l1− l2)xR2 (t)− l1xR3 (t)
)
− 1
l3η
λR
(
M(xR(t))−M∗R
)
u˜P(t) =−1
3
(
−xP1 (t)− xP2 (t)− xP3 (t)
)
− 1
10η
λP
(
M(xP(t))−M∗P
) (4.24)
A suitable choice of the values for the desired masses, M∗P and M∗R, drives the BIS level to a
desired value. In the same line of what was done for the NMB level, to compute these values, the
equilibrium points of the closed–loop system, when M(x) = M∗ were determined and the steady-
state effect concentrations cPe and c
R
e were shown to be equal to M
∗P/3 and M∗R/3, respectively,
as in Nogueira et al. (2014). This enables to determine the value of M∗P and M∗R by the inversion
of the Hill equation (4.14) for a desired steady-state value yre fBIS for the BIS level.
Indeed, on the one hand, we have
zre f =
(
97.7
yre fBIS
−1
)1/ζ
, (4.25)
and on the other hand,
zre f = m
(
cPe
)
re f
CP50
+
(
cRe
)
re f
CR50
. (4.26)
Thus, once the patient dependent parameters ζ and m are known, a value of zre f is obtained from
(4.25) that can be replaced in (4.26). This still leaves a degree of freedom to in the determination
of M∗P and M∗R from equation (4.26). To eliminate this degree of freedom, we assume that
M∗P = ρM∗R, for a fixed ρ ≥ 0. Using this assumption and equation (4.26) we obtain the desired
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system masses as,
M∗P =
3ρzre f
1
CP50
mρ+ 1CR50
M∗R =
3zre f
1
CP50
mρ+ 1CR50
.
(4.27)
Note that, in steady-state, the proportion M
∗P
M∗R = ρ implies
uP
uR = ρ .
Figures 4.3 and 4.4 show the performance of the positive control laws designed with the
parameters of the patient number 18 of the database presented in Appendix E, ξ18 = 0.1336,
η18 = 0.2307, m18 = 1.2061 and ζ18 = 1.0846. The design parameters λP and λR were both
chosen be equal to 1 and the proportion between the propofol dose and remifentanil dose, ρ , was
chosen be equal to 400 based on the proportion of the real doses administered during general
anesthesia; the desired BIS level was set at 50%. As one can see in Figure 4.3, the system mass
for both the propofol model and remifentanil models MP
(
xP(t)
)
and MR
(
xR(t)
)
converge to the
desired values, M∗P = 19.7276mg.ml−1 and M∗R = 0.0493mg.ml−1, respectively, and therefore
the BIS level reaches the BIS reference level of 50%. This reference was chosen based on the ade-
quate range values for the BIS level of a general anesthesia, which is between 40% and 60%. For
Figure 4.3: System mass evolution for the propofol model and for the remifentanil model.
overall assessment, Figure 4.5 illustrates the BIS level of the eighteen cases presented in Appendix
E when the control law for the propofol is given by (4.23) and the control law for remifentanil by
(4.24). The bottom plot represents the average BIS level response of the eighteen cases presented
in the upper plot and as expected the BIS level reaches the target value of 50%.
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Figure 4.4: BIS level evolution when the drug doses of propofol and remifentanil are determined
by the positive control laws.
Figure 4.5: BIS level evolution when the drug doses of propofol and remifentanil are determined
by the positive control laws for the eighteen cases of Appendix E (upper plot) and the average of
these eighteen signals (bottom plot). The dashed line represents the reference BIS level.
4.2 Simplified positive control law
In this section it is shown that the previously considered positive control law can be simplified.
More concretely, the parameters associated with the linear models can be fixed and the controllers
only depend on the parameters of the Hill equation. For this purpose, it is shown that the feedback
stabilization of the M(x) does not dependent on the parameter θ , when the patient is modeled by
a linear time-varying system with the following structure,
x˙(t) = θ Ax(t) + θ Bu(t), (4.28)
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For a control law with a structure as,
u(t) = max(0, u˜(t))
u˜(t) =−
(
n
∑
i=1
bi
)−1([
1 . . . 1
]
Ax(t)+λ (M (x(t))−M∗)
)
,
(4.29)
the effect of the simplified control law, assuming u˜(t)> 0, ∀t, is evaluated by the dynamics of the
system error mass
.︷︸︸︷
∆M (x):
.︷ ︸︸ ︷
∆M(x) =
.︷ ︸︸ ︷
M(x) =
[
1 . . . 1
]
x˙(t)
=
[
1 . . . 1
]
θAx+
[
1 . . . 1
]
θBu˜(t)
=
[
1 . . . 1
]
θAx+
[
1 . . . 1
]
θB
−( n∑
i=n
bi
)−1 [
1 . . . 1
]
Ax
−
(
n
∑
i=1
bi
)−1
λ (M(x)−M∗)

=−θλ (M(x)−M∗)
=−λθ∆M(x)
(4.30)
Thus, the patient parameter θ may indeed be left out of the control law. Although θ influences the
speed of convergence, this can be compensated by the design parameter λ . As it can be seen in
(4.30), the controller actions only depend on a suitable choice of the value for M∗.
The advantage of this simplified control law is the decrease of the number of parameters
needed to identify on real time and consequently the decrease of the errors associated with the
system identification. Furthermore, the effort of tuning the covariance matrices in the EKF algo-
rithm also decreases.
In the following sections, new controllers were designed according this simplification.
4.2.1 Simplified control for atracurium - NMB case
For the control of the NMB level, the simplified control law stays,
u(t) = max(0, u˜(t))
u˜(t) =− 1
k3
(
(k2− k3)x1+(k1− k2)x2− k1x3
)
− 1
k3α¯
λ
(
M(x(t))−M∗
)
,
(4.31)
where α¯ corresponds to the mean value for the parameter α , computed from our database. The
only parameter involved in the design of the positive control law is the parameter γ in the calcula-
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tion of the desired value for M∗, which is determined by equation (4.32)
M∗ = 3xe3 = 3c
re f
e (γ) =
(
100
yre fNMB
−1
)1/γ
C50 . (4.32)
In order to validate this approach, i.e., the use of the mean, α¯, of the parameter α to design the
controller, a real drug dose profile was administered to a simulated model presented in Appendix
B, under the conditions of the following two scenarios:
(1) The model is simulated with α = αi and γ = γi (i ∈ {, . . . ,100});
(2) The model is simulated with α = α¯ = 0.0382 and γ = γi (i ∈ {, . . . ,100});
Figure 4.6 shows the comparison of the NMB level simulated for the model i = 2 (α2 = 0.0412
and γ2 = 2.9740) when the real drug dose profile depicted in the upper plot is administered. The
data of this dose was collected during a general anesthesia. The blue line represents the NMB
level when the model is simulated under the conditions of scenario (1) and the red line is the NMB
level for scenario (2). For a global analysis, scenarios (1) and (2) were applied to the hundred
Figure 4.6: NMB level evolution for the scenarios (1) and (2) for patient number 2 for the real
dose administered during surgery, consisting of an initial bolus follows by a second bolus at time
instant t = 30min.
models presented in Appendix B with the real drug dose signal of Figure 4.6. The average of each
of response sets of signals was computed and illustrated in Figure 4.7. The maximum value of the
relative difference between the NMB levels obtained under the conditions of scenario (1) and (2)
is 5.92%.
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Figure 4.7: Mean value of NMB level evolution for the scenarios (1) and (2) for the hundred
simulated models.
These results support the use of this approach to design a positive control law.
Figure 4.8 shows the performance of the controller using the simplified control (SC) for the
same model of Figure 4.1, i.e., using the data set of the patient number 17 of Appendix B (α17 =
0.0366, γ17 = 1.9262) and using λ = 0.2. By comparing the two control schemes it is possible to
see that the performance of the simplified control is similar with the performance of the controller
when the parameters used to design the controller coincide with the parameters of the model. The
significant difference is the velocity of convergence of the M(x) to desired value M∗, and as was
already said, this can be overcome by adjusting the design parameter λ , as it is possible to see
in Figure 4.9 that shows the difference between the previous simulation when the parameter λ is
adjusted. For λ equal to 0.5 the obtained results are closer to the results obtained with α = αi and
γ = γi (i ∈ {1, . . . ,100}).
Figure 4.8: Comparison between the NMB level for the patient 17 obtained when the drug is
determined by the positive control law (blue line) and the NMB level obtained when the drug is
determined by the simplified positive control law (red line).
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Figure 4.9: Comparison between the NMB level obtained when the drug is determined by the pos-
itive control law (blue line) with λ = 0.2 and the NMB level obtained when the drug is determined
by the simplified positive control law (red line) with λ = 0.5.
4.2.2 Simplified control for remifentanil and propofol - BIS case
Using the same reasoning as for the NMB case, simplified control laws for propofol and for
remifentanil can be defined as in equations (4.33) and (4.34), respectively,
uP(t) = max
(
0, u˜P(t)
)
u˜P(t) =− 1
d3
(
(d2−d3)xP1 +(d1−d2)xP2 −d1xP3
)− 1
d3ξ¯
λ
(
M(xP(t))−M∗P
)
,
(4.33)

uR(t) = max
(
0, u˜R(t)
)
u˜R(t) =− 1
l3
(
(l2− l3)xR1 +(l1− l2)xR2 − l1xR3
)− 1
l3η¯
λ
(
M(xR(t))−M∗R
)
,
(4.34)
where ξ¯ and η¯ are the mean values for the parameters ξ and η , respectively, and the desired values
of, M∗P and M∗R, are obtained as,
M∗P =
3ρzre f
1
CP50
mρ+ 1CR50
M∗R =
3zre f
1
CP50
mρ+ 1CR50
,
(4.35)
where zre f is computed as,
zre f =
(
97.7
yre fBIS
−1
)1/ζ
. (4.36)
Similarly to what was done for the NMB level, the following two scenarios were applied to validate
this approach for the BIS case. The drug profile doses used to simulate the patient’s response are
the ones depicted in the lower plot of Figure 4.10 and correspond to the actual administered dose
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during surgery.
The following two scenarios were considered:
1. The model is simulated with ξ = ξi, η = ηi, m = mi and ζ = ζi (i ∈ {1, . . . ,18});
2. The model is simulated with ξ = ξ¯ = 0.0759, η = η¯ = 0.5825, m = mi and ζ = ζi
(i ∈ 1{, . . . ,18});
The bottom plot of Figure 4.10 shows the comparison of the BIS level simulated for the model
number 8 (ξ8 = 0.0860, η8 = 0.0212, m8 = 1.4203 and ζ8 = 0.9780). The blue line represents the
BIS level when the model is simulated under the conditions of the scenario (1) and the red line is
the BIS level for scenario (2) and it is possible to see that the obtained BIS level is almost equal.
Figure 4.10: BIS level evolution for the scenarios (1) and (2).
In the same line of what was done for the NMB level, scenarios (1) and (2) were be applied
to the eighteen models presented in Appendix E with the drug dose signals of Figure 4.10. The
mean of the signals were computed and illustrated in Figure 4.11. The maximum value between
the relative difference between the BIS level obtained under the conditions of scenario (1) and (2)
is 8.71%.
The results above the use of this approach to design suitable positive control laws.
Figure 4.12 shows the performance of the controller using the simplified control (SC) for
the same model of Figure 4.4, i.e., under the same conditions of patient number 18 and λ = 5.
As it already happened for the NMB case, the two controller responses are similar. Again, the
significant difference is the velocity of convergence of the BIS level to the BIS reference level.
Figure 4.13 shows the difference of the controlled signal when the controller is designed with
λ = 10. Although the convergence is not faster than the NMB case, these results give reason to its
application in a clinical environment.
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Figure 4.11: Average BIS level response evolution under scenarios (1) and (2) for the eighteen
simulated models.
Figure 4.12: Comparison between the BIS level obtained when the drug doses are determined by
the positive control laws (blue line) and the BIS level obtained when the drug doses are determined
by the simplified positive control laws (red line).
4.3 Control scheme with parameter identification
In the previous simulations we assume that the patient dependent parameters are known and conse-
quently the exact control law is also known. However, this does not happen in a real environment.
So, with the purpose to apply the proposed simplified positive control law in the real environment,
a control scheme with parameter identification is proposed in this section.
Figure 4.14 schematizes the control scheme for drug administration with identification. The
signals u(t) and y(t) are the input signals for the extended kalman filter (EKF). Until a certain time
instant, this algorithm learns with the real signals and identifies the patient dependent parameters.
The parameters identified are used to simulate the patient and to design the controller law that
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Figure 4.13: Comparison between the BIS level obtained when the drug doses are determined by
the positive control laws (blue line) with λ = 5 and the BIS level obtained when the drug doses
are determined by the simplified positive control laws (red line) with λ = 10.
computed the system input, u(t). In the next two sections the results for the NMB control and for
u(t) +
−
y(t)
Patient
t < t∗
EKF
+
−
+
−
Simulated
Patient
t ≥ t∗ yˆ(t)
Controller
Figure 4.14: Block diagram of the control scheme where the patient dependent parameters are
identified by the EKF algorithm.
the BIS control when this control scheme is applied are presented.
4.3.1 Simplified control scheme for atracurium - NMB case
Applying the scheme of Figure 4.14 to the NMB case, the control approach is summarized by the
following steps:
1. An initial bolus of atracurium is administered to the patient;
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2. After a certain time instant, the patient begins to recover from the initial bolus. This time
instant is obtained using the algorithm OLARD, Silva et al. (2009). This algorithm detects
the initial recovery time, t∗. At this time instant, the continuous drug infusion starts;
3. For t < t∗, the algorithm EKF identifies the patient dependent parameter γ .
4. For t ≥ t∗, the control law (4.31) computes the atracurium dose using α = α¯ and γ = γˆ(t∗);
The drug dose is computed in order to achieve the desired value of 10% for the NMB level.
To validate this approach the data of 10 real cases collected during a general anesthesia were used.
More concretely, a comparison between the amount of drug given by the anesthesiologist and the
controller was performed. The profile of these real responses and the real doses are illustrated in
Appendix C. The data set is composed by six female cases with 58 ± 19 years of age and four
male cases with 60 ± 22 years of age.
In Figure 4.15, it is possible to see the comparison between the amount of drug given by the
anesthesiologist and the amount of the drug computed by the control scheme presented in this
thesis. The bottom plot shows the NMB level obtained by administering the controlled drug dose.
The data of this simulation corresponds to the data of patient number 8 of Appendix C. The case
depicted in Figure 4.15 is a good case to show that the use of a controller allows to stabilize the
patient’s response. The controller begins at t∗ = 31min (time instant determined by the algorithm
OLARD) and was designed with α¯ = 0.0382 and γˆ = 2.558 (value obtained by the identification
performed by the EKF at t = t∗).
Figure 4.15: In the upper plot the atracurium dose given by the control scheme (red line) is
represented and compared with the dose administered by the clinician in a general anesthesia
(blue line). The bottom plot shows the corresponding NMB level. ySC+idNMB represents the NMB level
obtained by applying the simplified control with parameter identification and yrealNMB represents the
real NMB level collected during the general anesthesia procedure.
In this example, the total amount of atracurium given by the controller is higher (∑uSC =
7065µg.kg−1.min−1) than the total real amount (∑ureal = 5000µg.kg−1.min−1).
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Figure 4.16 shows the difference between the total amount of atracurium dose administered
during the general anesthesia and the total amount dose obtained by the controller for all the 10
cases. As it is possible to see, the total amount of dose is always higher in the case it is computed
by the proposed control scheme. However, this is compensated by an NMB level closer to the
reference NMB level 10%. This fact is illustrated in Figure 4.17, which represents the mean of the
NMB level between in the time interval [ti, t f ], where ti corresponds to the first time instant when
the NMB level is lower than 10%. This time instant was chosen to analyze the NMB level without
considering the abrupt variation in the beginning of the anesthesia procedure. The time instant t f
corresponds to the time where the surgery ends.
Figure 4.16: Total amount of atracurium administered during the surgery (red star) and the total
amount determined by the control scheme (blue bullet). ∑uSC+id represents the total amount dose
obtained by the simplified control with parameter identification and ∑ureal represents total amount
of the real dose administered during general surgeries.
In order to analyze the trade-off between the amount of the drug and the NMB level, for each
case, the following cost functional was considered
J =
1
n
n
∑
t=0
((
yre fNMB− yNMB(t)
)2
+ κu2(t)
)
, (4.37)
where the gain κ was chosen to be equal to 1. This choice was made to be in accordance with the
weight parameters chosen for the optimal control problem in the next chapter.
Figure 4.18 shows the difference of the cost for the 10 real cases and the cost for these cases
when the control scheme was applied.
As it is possible to see the cost functional is higher when the real signals yNMB(t) and u(t) are
considered. In order to justify and to reflect the real behavior in the control scheme, the NMB
reference level was changed for the mean value of the real NMB level presented in Figure 4.17
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Figure 4.17: Mean of the real NMB level between the time instants ti and t f (red star) and mean
of the simulated NMB level in the same time interval (blue bullet). ti is the first time instant where
the response is lower than 10% and t f is the time instant when the surgery ends. ySC+idNMB represents
the mean of the NMB level between in the time interval [ti, t f ] obtained by the simplified control
with parameter identification and yrealNMB represents the mean of the real NMB level between in the
time interval [ti, t f ].
Figure 4.18: Cost value obtained for the real cases (blue bullet) and the cost value obtained for
the control scheme (red star). JSC+id represents the cost value obtained using the signals obtained
by the simplified control with parameter identification and Jreal represents the cost value obtained
using the real signals obtained during general surgeries.
(red star). As expected, the total amount of drug given by the controller decreases, but is still
higher than the total amount of the real drug administered. However, as it is possible to see in
Figure 4.19, the difference is smaller than the difference depicted in Figure 4.16.
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Figure 4.19: Total amount of atracurium administered during the surgery (red star) and the total
amount determined by the control scheme (blue bullet) when the NMB reference level is taken to
be equal to the mean of the real NMB level between the time instants ti and t f . ti is the first time
instant where the response is lower than 10% and t f is the time instant when the surgery ends.
4.3.2 Simplified control scheme for remifentanil and propofol - BIS case
This section presents the results for the proposed control scheme for the BIS case. The control
approach is applied according the same scheme as in Figure 4.14. There are, however, some
differences with respect to the NMB case, as an initial drug bolus is not given. The procedure is
now as follows.
1. The anesthesiologists start the continuous infusion of propofol and remifentanil;
2. For t < t∗ = 4min the EKF algorithm identifies the patient dependent parameters m and
ζ . The instant t∗ was empirically chosen based on the minimal time during which the two
drugs are administered in the real cases;
3. For t ≥ t∗ = 4min the control laws (4.33) and (4.34) compute the amount of propofol and
remifentanil, respectively, using ξ = ξ¯ , η = η¯ , m = m(t∗) and ζ = ζ (t∗). The dosages uP
and uR of the two drugs are computed in order to achieve a BIS reference level of 50%. The
chosen relation between these dosages is uP = ρuR with ρ = 400.
This approach was validated using the data presented in Appendix E. Figure 4.20 shows the perfor-
mance of the control scheme for a patient with the same data as patient number 18. The EKF algo-
rithm identified the parameters m and ζ at t∗ = 4min and the values obtained were m(t∗) = 1.998
and ζ (t∗) = 1.001. Unlike for the NMB case, for the BIS the total amount of drug is higher in
the real practice than using the control law. Moreover, the simulated BIS level obtained with the
controller is closer to the BIS reference level 50% (desired level during a general anesthesia).
The performance of the control scheme was evaluated in the same way as for the NMB case.
Figure 4.21 illustrates the amount of drugs actually administered during the real surgery and the
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Figure 4.20: The upper plot shows the BIS level obtained when the profile of the drug doses
represented in the bottom plot are administered. ySCBIS represents the BIS level obtained using the
simplified controller, yrealBIS is the real BIS level signal and y
re f
BIS is the BIS reference level; u
PSC and
uPreal represent the propofol doses obtained by the simplified controllers and the ones obtained for
the real cases (in clinical environment), respectively, and uRSC and uRreal represent the remifentanil
doses obtained by the simplified controllers and the ones obtained for the real cases (in clinical
environment), respectively.
ones computed by the controllers, whereas Figure 4.22 shows the mean value of the corresponding
BIS levels between ti and t f . Figure 4.23 shows the cost functional (4.38) obtained with the real
signals and the one obtained with the simulated signals. In this case, the time instant ti corresponds
to the first time instant when the real response is lower than the desired value 50% and t f represents
the end of the surgery.
The cost functional for the BIS level was computed using the following equation,
J =
1
n
n
∑
t=0
((
yre fBIS− yBIS(t)
)2
+ κ
(
uP(t)+uR(t)
)2)
, (4.38)
κ = 10, according the value chosen in the next chapter.
As it is possible to see, the cost functional is higher for the real cases, which means that the
trade-off between the amount of drug administered and the tracking of the BIS reference is worst
than the control approach. These results encourage the application of this control scheme in real
environment.
An advantage of using an online identification method is the possibility of readjusting the
parameter estimation and consequently to adjust the control scheme. Figure 4.24 shows the differ-
ence between the BIS evolution for the patient number 13 when the parameters are identified only
at t∗ = 4min and when the parameters are identified in two different instant times, t∗ = 4min and
t∗ = 8min. In the latter case, the variability of the parameter identification was low, the parameter
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Figure 4.21: The left plot represents the total amount of propofol administered during the surgery
(red star) and the total amount determined by the control scheme (blue bullet). The right plot
presents the total amount of administered remifentanil in the same conditions. ∑uPSC+id and
∑uPreal represent the propofol doses obtained by the simplified controllers with parameter iden-
tification and the ones obtained for the real cases (in clinical environment), respectively, and
∑uRSC+id and ∑uRreal represent the remifentanil doses obtained by the simplified controllers with
parameter identification and the ones obtained for the real cases (in clinical environment), respec-
tively.
m remained the same and the parameter ζ changed from 2 to 1.999. However, as it is possible to
see in Figure 4.24 the obtained response is considerably better.
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Figure 4.22: Mean of the real BIS level between the time instants ti and t f (red star) and mean of
the simulated NMB level in the same time interval (blue bullet). ti is the first time instant where
the response is lower than 50% and t f is the time instant when the surgery ends. ySC+idBIS represents
the mean of the BIS level between in the time interval [ti, t f ] obtained by the simplified control
with parameter identification and yrealBIS represents the mean of the real BIS level between in the
same time interval.
Figure 4.23: Cost values obtained for the real cases (blue bullet) and for the control scheme (red
star). JSC+id represents the cost value obtained using the signals obtained by the simplified control
with parameter identification and Jreal represents the cost value obtained using the real signals
obtained during the general surgery.
Figure 4.24: Comparison between the BIS response when the parameters are identified at t∗ =
4min and t∗ = 8min and the BIS response when the parameters are only identified at t∗ = 4min.
yrealBIS represents the real BIS level collected during the general anesthesia procedure, y
SC+id
BIS rep-
resents the BIS level obtained by applying the simplified control with parameter identification,
ySC+id+idBIS is the signals obtained where the parameter identification is adjusting at t
∗ = 8min, yrealBIS
represents the BIS reference level and + is the time instant where the parameter identification is
adjusting.
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Figure 4.25: Comparison between the BIS response when the parameters are identified at t∗ =
4min and t∗ = 8min. The two markers in the x-axis, respectively, indicate the instants when the
parameters and the BIS reference level were readjusted. yrealBIS represents the real BIS level collected
during the general anesthesia procedure, ySC+id+idBIS represents the BIS level obtained by readjusting
of the simplified control and yre fBIS represents the BIS reference level.
Moreover, as it is possible to see in Figure 4.25, the law patient’s response adapts well its
behavior when there is a change in the desired BIS reference level used in the control law, during
the procedure. Figure 4.25 shows the performance of the control scheme when the parameters
identification are readjusted at t∗ = 8min and when the BIS reference level is chosen to be equal
to 40% after t = 23min. The change of the BIS reference level may be necessary due to clinical
demands.
In this chapter, a simplified positive control law was proposed, and its simulated application in
the real environment was compared, through a cost functional, with the real patient responses to
the drug administered by the anesthetist.
5Controllers based on optimal control
This section presents a state-feedback controller design method based on optimal control. Here the
reference tracking problem is formulated as an optimal control problem with inequality constraints
in the input. In turn, the optimal control problem (OCP) is relaxed into a semi-definite program
(SDP) by replacing the original variables by their moments up to a certain order in the same line
of what is done in Lasserre (2009), Lasserre et al. (2008). The optimal values of the moments
can then be computed by semi-definite programming solvers Sturm (2013), Lofberg (2004), Grant
and Boyd (2015) and the gains of the state-feedback control law are then computed based on these
values. Although the obtained control law is only an approximation of the optimal solution, this
approach has the advantage of easily coping with state and input constraints.
We formulated the output optimal control problem for the reference tracking problem in terms
of optimal control as follows. Suppose that, given a state-space system
{
x˙ = Ax+Bu
c = C x
(5.1)
one wishes to design a positive control law so as to obtain u(t)≥ 0 that drives the system output c
to a reference value ce. Assume further that the output reference value ce corresponds to a system
set-point (equilibrium) (x(t),u(t),c(t)) ≡ (xe,ue,ce), for t ≥ 0. Such set-point can be computed
from the equations:
{
0 = Axe+Bue
ce = C xe
(5.2)
Define the following errors with respect to the set-point: xˆ(t) = x(t)− xe, uˆ(t) = u(t)−ue and
cˆ(t) = c(t)− ce. Clearly, the new variables satisfy the equations:
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{
xˆ(t) = Axˆ+Buˆ
cˆ(t) = C xˆ
(5.3)
Finally, consider the optimal control problem:
min
uˆ(t),t f
J (xˆ(t), uˆ(t)) =
1
2
∫ t f
t∗
xˆT(t)Qxˆ(t)+ uˆT(t)Ruˆ(t)︸ ︷︷ ︸
h(xˆ(t),uˆ(t))
dt
s.t. ˙ˆx(t) = Axˆ(t)+Buˆ(t)︸ ︷︷ ︸
f (xˆ(t),uˆ(t))
xˆ(t∗) = xˆ0 (5.4)
xˆ(t f ) = [0 . . . 0]
T
uˆ(t) ∈ G
where Q = QT > 0 and R = RT > 0 are design matrices, t∗ is the time instant when the controller
action begins, h(xˆ(t), uˆ(t)) and f (xˆ(t), uˆ(t)) are homogeneous quadratic polynomial functions and
G is the constrained region for the input values, uˆ, which is a set defined as
G = {uˆ(t) : g(uˆ(t))≥ 0, ∀t ≥ 0} ,
where g(uˆ(t)) is a polynomial function.
Note that the final state restriction xˆ(t f ) = [0 . . . 0]
T forces the tracking error to be zero at
time t f .
LMI relaxation into a semi-definite program
This section follows closely the method proposed in Lasserre (2009), Lasserre et al. (2008).
In order to obtain an approximate solution of the previous OCP, a change of variables to transform
this problem into an SDP is made. For this purpose the new variables are defined as the moments
of x¯ = (xˆ , uˆ), i.e.,
yβ =
∫ T
0
x¯β dt , (5.5)
where β = (β1, . . . ,βn,βn+1) is a multi-index, x¯β =∏ x¯
βi
i and T is the final time instant.
To transform a polynomial into a moment we follow a similar procedure to what is done in
Lasserre (2009). To that end, given a polynomial p(x¯) = ∑
β∈Nn+1
pβ x¯
β , a linear bounded functional
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L is defined as
L(p) = ∑
β∈Nn+1
pβ yβ . (5.6)
This amounts to replacing the monomials in p by the corresponding integrals, according to
(5.5). Based on the moments yβ with β ∈Bd def= {(β1, . . . ,βn+1) ∈ Nn+1 : ∑n+1j=1 β j ≤ d} one also
introduces the moment matrix of order d, Md(y), which plays an important role in the reformula-
tion of the OCP (5.4). The moment matrix has rows and columns labeled by
Vd(x¯) =
[
1, x¯1, . . . , x¯n+1, x¯21, x¯1x¯2, . . . , x¯1x¯n+1, x¯
2
2, x¯2x¯3, . . . , x¯2x¯n+1, . . . , x¯
2
n+1, . . . , x¯
d
n+1
]
(5.7)
and is constructed as
Md(y) = L
(
Vd(x¯)Vd(x¯)T
)
(5.8)
with L as defined in (5.6). This means that L is applied to each entry of the matrix Vd(x¯)Vd(x¯)T .
As a consequence, the cost functional J(xˆ(t), uˆ(t)) can be rewritten as
L(h) =
1
2∑β
hβ yβ , (5.9)
where hβ are the coefficients of the polynomial h(xˆ(t), uˆ(t)) in the OCP formulation (5.4).
To incorporate the system dynamics and the end-point constraints as constraints of the semi-
definite program, monomial test functions υ(xˆ) are considered. These functions are polynomials
given by υ(xˆ) = xˆβ . Note that, on one hand, from the Fundamental Theorem of Calculus:
∫ T
0
dυ (xˆ(t))
dt
dt = υ (xˆ(T ))−υ (xˆ(0)) , (5.10)
and on the other hand, using the chain rule and the system dynamics the total time derivative is
equal to:
dυ(xˆ)
dt
=
∂υ
∂ xˆ
· dxˆ
dt
=
∂υ
∂ xˆ
· f (xˆ(t),u(t)) . (5.11)
Thus for each function υ(xˆ) one obtains:
∫ T
0
∂υ
∂ xˆ
· f (xˆ(t), uˆ(t)) d t = υ(xˆT )−υ(xˆ0) ∀υ . (5.12)
Since f is a polynomial function of xˆ and uˆ and υ and ∂υ∂ xˆ are polynomial functions of xˆ this
equation can be rewritten in terms of the moments as ∑ j ai jyα j = bi, where ai j are the coefficients
of the moments for i = 1, . . . ,M. The positive integer M represents the number of all possible
combinations of the exponents in the polynomial v(xˆ) so that they are not all zero and their sum is
less or equal to d. For better understanding, consider the following example: if there are three state
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variables then v(xˆ) = xˆβ11 xˆ
β2
2 xˆ
β3
3 and if d = 2 then all possible combinations such that β1+β2+β3≤
d yield M = 9 as will be detailed in subsection 5.1.
To handle the state and input constraints the localizing matrix Md(gy) with respect to y and to
the polynomial g(uˆ(t)) is defined. This matrix is given by
Md(gy) = L
(
gVd(x¯)Vd(x¯)T
)
, (5.13)
with Vd(x¯) defined in (5.7). The dimensions of Md(gy) will be such that its entries are moments of
order less or equal to d. Therefore, Md(gy) is always of smaller dimension than Md(y). The OCP
(5.4) can then be rewritten as
min
y
L(h)
s.t. ∑
j
ai jyα j = bi, i = 1, . . . ,M
Md(y)≥ 0 (5.14)
Md(gy)≥ 0
According to Lasserre (2009), the advantage of reformulating the original problem as a SDP
is that this approximation has revealed to be fast from a computational point of view and often
presents finite convergence to the global optimum.
This problem is solved using software with an SDP solver such as the ones proposed in Sturm
(2013), Lofberg (2004), Grant and Boyd (2015), and the values of the optimal moments yβ = y∗β
are obtained. Then, a state feedback control input
uˆ(t) =
n
∑
i=1
Ki xˆi(t) . (5.15)
with unknown gains Ki can be determined by replacing (5.15) in the moments that involve uˆ and
recasting them in terms of the moments involving the state. For instance, for a simple system with
two state components, xˆ1, xˆ2 and one input uˆ, the moment y101, where the first index indicates the
order of the moment in xˆ1, the second index in xˆ2 and the third index in uˆ, becomes:
y101 =
∫ T
0
xˆ1(t)uˆ(t)dt =
∫ T
0
xˆ1(t)(K1xˆ1(t)+K2xˆ2(t)) dt
=
∫ T
0
K1xˆ21(t)+K2xˆ1(t)xˆ2(t)dt
= K1y200+K2y110 (5.16)
Proceeding in the same way for the other moments involving the input yields a system of linear
equations where the unknowns are the feedback gains and the coefficients and independent terms
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are the moments. After the values of the optimal moments are obtained the feedback gains can be
computed whenever the system of linear equations has a solution.
Remark: Note that two approximations have been made that led to the LMI relaxation when
compared to the original problem. First, the considered moment matrix has finite order d. Al-
though, the approximation converges to the optimal solution d→∞ (under some mild assumptions
stated in Lasserre (2009), Lasserre et al. (2008)), the theoretical guarantees on the input verifying
the constraints in the case of the original optimal control problem might be lost in the relaxed
solution for a finite d. For linear quadratic problems the hope is that an order d = 2 will be enough
based on what happens for the Linear Quadratic Gaussian (LQG) problem, Bellman (1957), but
there is no guarantee that this is correct when there are constraints on the state and/or on the input.
Due to this reason, it is necessary to check a-posteriori in simulation if the obtained approximate
solution indeed satisfies the original constraints for the set of possible initial conditions of interest
to a given application. Second, after computing the approximation of order d for the moment
matrix we assumed that the control input was a linear state feedback. Therefore, the solution to
this problem (i.e., the computed optimal moments and corresponding feedback gain) is only an
approximation to the solution of the OCP.
5.1 Optimal control for atracurium - NMB case
To design a feedback control law to track a desired NMB reference level, yre fNMB, the optimal control
problem is formulated as:
min
uˆ(t),t f
J (xˆ(t), uˆ(t)) =
1
2
∫ t f
t∗
xˆT(t)Qxˆ(t)+ uˆT(t)Ruˆ(t)dt
s.t. ˙ˆx(t) = Axˆ(t)+Buˆ(t)
xˆ(t∗) = xˆ0 = eAt
∗
500B− xe (5.17)
xˆ(t f ) = [0 0 0]
T
uˆ(t) ∈ G = {uˆ(t) : uˆ(t)+ue ≥ 0, ∀t ≥ 0}
with Q = QT > 0 and R = RT > 0 are design matrices, xˆ(t) = x(t)− xe, uˆ(t) = u(t)− ue, xe =[
1 1 1
]T
ue, ue =
(
100
yre fNMB
−1
)1/γ
C50, and the column-matrix A and the vector B given by
A =
−α k3 0 0α k2 −α k2 0
0 α k1 −α k1
 and B =
α k30
0
 ,
for the fixed values of k1 = 1, k2 = 4, k3 = 10 and C50 = 3.2435. Note that, (xe,ue,cee = u
e) is the
set-point for the linear part of the NMB model (eq. 2.12) corresponding to the NMB level yre fNMB.
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Moreover, x(t∗) = eAt∗500B is the state at time t∗ corresponding to the administration of an initial
bolus of 500µg/kg of atracurium, as is usually done in clinical practice.
The cost functional in (5.17) is replaced by the moments and becomes equal to
1
2
(q1 y2000 + q2 y0200 + q3 y0020 + r y0002)
The test functions are v(xˆ) = xˆβ11 xˆ
β2
2 xˆ
β3
3 , with the exponents given in Table 5.1.
Table 5.1: Exponents β for test function v(xˆ)
β1 β2 β3
1 0 0
0 1 0
0 0 1
1 1 0
1 0 1
0 1 1
2 0 0
0 2 0
0 0 2
The moment order was restricted to be d = 2. For moments of order up to d = 2, all possi-
ble combinations for the exponents are indicated in Table 5.1. The equality constraint equations
corresponding to the entries in Table 5.1 are
k3α (y0001− y1000)+ xˆ1(t∗) = 0
k2α (y1000− y0100)+ xˆ2(t∗) = 0
k1α (y0100− y0010)+ xˆ3(t∗) = 0
k3α (y0101− y1100)+ k2α (y2000− y1100)+ xˆ1(t∗)xˆ2(t∗) = 0
k3α (y0011− y1010)+ k1α (y1100− y1010)+ xˆ1(t∗)xˆ3(t∗) = 0
k2α (y1010− y0110)+ k1α (y0200− y0110)+ xˆ2(t∗)xˆ3(t∗) = 0
2k3α (y1001− y2000)+ xˆ21(t∗) = 0
2k2α (y1100− y0200)+ xˆ22(t∗) = 0
2k1α (y0110− y0020)+ xˆ22(t∗) = 0
The optimal moment matrix Md(y∗) is the obtained after the optimal moments, y∗, are com-
puted by numerical solvers, e.g., CVX, Grant and Boyd (2015).
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M∗ = Md(y∗) =

y∗0000 y
∗
1000 y
∗
0100 y
∗
0010 y
∗
0001
y∗1000 y
∗
2000 y
∗
1100 y
∗
1010 y
∗
1001
y∗0100 y
∗
1100 y
∗
0200 y
∗
0110 y
∗
0101
y∗0010 y
∗
1010 y
∗
0110 y
∗
0020 y
∗
0011
y∗0001 y
∗
1001 y
∗
0101 y
∗
0011 y
∗
0002
≥ 0
Finally, the feedback gains can be computed from the following system of linear equations:
M
∗(2,5)
M∗(3,5)
M∗(4,5)
=
M
∗(2,2) M∗(2,3) M∗(2,4)
M∗(3,2) M∗(3,3) M∗(3,4)
M∗(4,2) M∗(4,3) M∗(4,4)

K1K2
K3

(5.18)
where M∗(i, j) denotes the (i, j) entry of the matrix M∗.
In order to simulate the performance of the computed feedback control laws the bank of hun-
dred models with parameters θi = (αi,γi) (i = 1, . . . ,100) of Appendix B was considered. The
data of the case number 2 was chosen as in the previous chapter. As mentioned before, the desired
NMB reference level is yre fNMB = 10%.
The control strategy used here can be summarized by the following steps:
• First, an initial bolus of muscle relaxant of atracurium is administered;
• The patient’s response is monitored to determine the recovery time instant t∗ using the al-
gorithm OLARD, Silva et al. (2009);
• After time t∗ the feedback gain matrix obtained by one of the previously described design
methods is used and the state feedback controller is activated.
In order to compare this approach with the one presented in Chapter 4, the following results
were obtained using the same scenarios considered in the that chapter. First, we compare the
performance of a controller designed with α = αi and γ = γi with a controller designed with
α = α¯ and γ = γi, i ∈ {1, . . . ,100}. The data set chosen corresponds to the patient i = 2 in the
database presented in Appendix B.
Scenario 1: Results obtained using α2 and γ2 to design the controller:
The next results were obtained using α = α2 = 0.0412 and γ = γ2 = 2.9740 in the OCP
formulation (5.17). For these values of parameters the state vetor at t = t∗ = 28.7min is
given by,
60 Controllers based on optimal control
x(t∗) =
0.00191.3215
9.1216
 (5.19)
We also considered that Q =CTC and R = 1, where C =
[
0 0 1
]
as in (2.12). For this
data set, the optimal moment matrix obtained by the solver, CVX Grant and Boyd (2015),
minimizing y0020+y0002 subject to the inequality constraints and Md(y)≥ 0, Md(gy)≥ 0 is
M∗ = Md(y∗) = 103

246.49 −0.0038 −0.0041 0.2255 −0.0038
−0.0038 0.0219 0.0113 −0.1383 0.0219
0.0042 0.0113 0.0162 −0.0488 0.0071
0.2255 −0.1383 −0.0488 0.9607 −0.1533
−0.0038 0.0218 0.0071 −0.1533 0.0245
 ,
and the feedback gains can be computed from the following system of linear equations:
M
∗(2,5)
M∗(3,5)
M∗(4,5)
=
M
∗(2,2) M∗(2,3) M∗(2,4)
M∗(3,2) M∗(3,3) M∗(3,4)
M∗(4,2) M∗(4,3) M∗(4,4)

K1K2
K3

(5.20)
yielding
KLMI =
[
−0.0122 −0.0447 −0.1636
]
Figure 5.1 shows the simulation of the NMB level response. As can be seen in Figure 5.1, the
control input u(t) is always non-negative. It can be shown that, due to the compartmental
structure of the system, this implies that also the state components x = xˆ+ xre f are non-
negative. Therefore, the original problem constraints are indeed satisfied. One can also
observe that the NMB level settles to the set-point of 10%.
Scenario 2: Results obtained using α¯ and γ2 to design the controller:
Here, the controller was designed using α = α¯ = 0.0382 and γ = γ2 = 2.9740 in the OCP
formulation 5.17. The matrices of the cost functional were assumed to be Q = CTC and
R = 1. For this data set, the optimal moment matrix obtained by the solver CVX, Grant and
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Figure 5.1: Simulation of the NMB level response (upper plot) using the state-feedback control
(bottom plot) given by the moment relaxation design method.
Boyd (2015), minimizing y0020 + y0002 subject to the inequality constraints and Md(y) ≥
0, Md(gy)≥ 0 is
M∗ = Md(y∗) = 103

268.02 −0.0035 0.0051 0.2439 −0.0035
−0.0035 0.0236 0.0123 −0.1492 0.0236
0.0051 0.0122 0.0179 −0.0527 0.0077
0.2439 −0.1492 −0.0527 1.0364 −0.1654
−0.0035 0.0236 0.0077 −0.1654 0.0264
 ,
and the feedback gains can be computed from the following system of linear equations:
M
∗(2,5)
M∗(3,5)
M∗(4,5)
=
M
∗(2,2) M∗(2,3) M∗(2,4)
M∗(3,2) M∗(3,3) M∗(3,4)
M∗(4,2) M∗(4,3) M∗(4,4)

K1K2
K3

(5.21)
yielding
KLMI =
[
−0.0121 −0.0447 −0.1636
]
.
Figure 5.2 shows a comparison between the results obtained under the conditions of scenar-
ios 1 and 2. Again, the control input u(t) is always non-negative and, consequently, the sate
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components x = xˆ+ xre f are non-negative. Therefore, the original problem constraints are
indeed satisfied. One can also observe that the NMB level settles to the set-point of 10%.
Figure 5.2: Simulation of the NMB level response (upper plot) using the state-feedback control
(bottom plot) given by the moment relaxation design method, both for the scenarios 1 (u and yNMB)
and 2 (uSC and ySCNMB)
.
Results obtained using the parameters identified by the EKF
Finally, Similarly to what was done for the previously proposed positive control law, here
we combine the control with the parameter identification performed by the EKF algorithm.
For that end, the real case number of 8 of Appendix C was used as in the previous chapter.
For this purpose the patient’s data (γ) identified by the EKF algorithm identified at the time
instant t∗= 31min is γˆ = 2.558. The controller was thus designed using α = α¯ = 0.0382 and
γ = γˆ(t∗) = 2.558 in the OCP formulation (5.17). Again, the matrices of the cost functional
were assumed to be Q=CTC and R= 1. The optimal moment matrix obtained by the solver,
CVX Grant and Boyd (2015), minimizing y0020+ y0002 subject to the inequality constraints
and Md(y)≥ 0, Md(gy)≥ 0 is
M∗ = Md(y∗) = 103

262.64 −0.0045 0.0041 0.2429 −0.0045
−0.0045 0.0236 0.0122 −0.1492 0.0236
0.0041 0.0122 0.0179 −0.0527 0.0077
0.2429 −0.1492 −0.0527 1.0364 −0.1653
−0.0045 0.0236 0.0077 −0.1654 0.0264

And the feedback gains can be computed from the following system of linear equations:
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M
∗(2,5)
M∗(3,5)
M∗(4,5)
=
M
∗(2,2) M∗(2,3) M∗(2,4)
M∗(3,2) M∗(3,3) M∗(3,4)
M∗(4,2) M∗(4,3) M∗(4,4)

K1K2
K3

(5.22)
yielding
KLMI =
[
−0.0123 −0.0447 0.1636
]
Figure 5.3 shows the simulation of the NMB level response. Again, the control input u(t)
is always non-negative which implies that also the state components x = xˆ+ xre f are non-
negative. Therefore, the original problem constraints are indeed satisfied. One can also
observe that the NMB level settles to the set-point of 10%.
Figure 5.3: Simulation of the NMB level response (upper plot) using the state-feedback control
(bottom plot) given by the moment relaxation design method. ySC+idNMB represents the NMB level
obtained using the state-feedback control with parameter identification, yrealNMB is the real NMB
signal obtained during a general surgery and yre fNMB is the reference NMB level.
Similarly to what was done to evaluate the control approach for the NMB level in Chapter 4,
Figure 5.4 shows the amount of drug given by the controller compared with the real amount
of drug administered. As it is possible to see the amount of drug given by the controller
is higher than the amount of drug given by the clinicians. However, as it is possible to see
in Figure 5.5, the control approach is much better in stabilizing the NMB level near of the
NMB reference level.
The relationship between the amount of drug administered and the NMB level is again
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Figure 5.4: Total amount of atracurium administered during the surgery (red star) and the total
amount determined by the control scheme (blue bullet). ∑uSC+id is the total amount of atracurium
administered using the state-feedback control with parameter identification and ∑uSC is the total
amount of atracurium administered to the 10 real cases of the database of Appendix C
.
Figure 5.5: Mean of the real NMB level between the time instants ti and t f (red star) and mean
of the simulated NMB level in the same time interval (blue bullet) for 10 cases of the database
of Appendix C. ti is the first time instant where the response is lower than 10% and t f is the time
instant when the surgery ends. y¯SC+idNMB is the mean of the NMB level obtained using the state-
feedback control with parameter identification in that time interval and y¯realNMB is the mean of the
real NMB level for the 10 cases of the database of Appendix C.
evaluated by the cost functional,
Ji =
1
n
n
∑
t=0
((
yre fNMB− yNMB(t)
)2
+ κu2(t)
)
, i = 1, . . . ,10 (5.23)
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with κ = 1. Although the amount of drug given by the controller is higher than the real case,
the cost functional for the control approach is lower than the real case. So, we can conclude
that the trade-off between the amount of drug and the quality of tracking the desired NMB
level is compensated in our control approach. This result is corroborated by the results
depicted in Figure 5.6
Figure 5.6: Cost value obtained for the real cases (blue bullet) and the cost value obtained for the
control scheme (red star) for 10 cases of the database of Appendix C. JSC+id is the cost value for
the signals obtained using the state-feedback control with parameter identification and JSC+id is
the cost value obtained using the real signals collected in the clinical practice.
5.2 Optimal control for remifentanil and propofol - BIS case
In this section an optimal control problem is formulated in order to track a desired BIS
level. Each drug will be controlled separately, i.e., an OCP will be formulated to design a
controller for propofol dose and another one to control the remifentanil dose.
The optimal control problem associated to the propofol dynamics is formulated as,
min
uˆP(t),t f
J
(
xˆP(t), uˆP(t)
)
=
1
2
∫ t f
t∗
(
xˆP
)T
QxˆP(t)+
(
uˆP
)T
RuˆP(t)︸ ︷︷ ︸
hP(xˆP(t),uˆP(t))
dt
s.t. ˙ˆxP(t) = AP xˆP(t)+BP uˆP(t)︸ ︷︷ ︸
f P(xˆP(t),uˆP(t))
xˆP(t∗) =−(xR)e (5.24)
xˆP(t f ) = [0 0 0]
T
uˆP(t) ∈ G P =
{
uˆP(t) : uˆP(t)+
(
uP
)e ≥ 0, ∀t ≥ 0}
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with xˆP(t) = xP(t)− (xP)e, uˆP = uP− (uP)e, xˆP0 = −(xP)e, the matrix AP and the column-
matrix BP are defined by,
AP =
−ξd3 0 0ξd2 −ξd2 0
0 ξd1 −ξd1
 , BP =
ξd30
0
 , (5.25)
d1 = 1, d2 = 9 and d3 = 10. As mentioned in Section 4.1.2, the vector
(
xP
)e has all entries
equal to
(
uP
)e, i.e.,
(
xP
)e
=
[
1 1 1
]T (
uP
)e
and (uP)e =
ρze
1
CP50
mρ+ 1CR50
(5.26)
where CP50 = 10mg.ml
−1 and CR50 = 0.1mg.ml
−1, ze is the desired BIS reference level and ρ
is to be fixed.
For the same reason as mentioned before, the moment order was restricted to be d = 2 and
all possible combinations for the exponents of the test functions, v(xˆP) = xˆP1
β1
xˆP2
β2
xˆP3
β3
, are
indicated in Table 5.1. The equality constraint equations corresponding to the entries of the
Table 5.1 for the propofol model are,
d3ξ
(
yP0001− yP1000
)
+ xˆP1 (t
∗) = 0
d2ξ
(
yP1000− yP0100
)
+ xˆP2 (t
∗) = 0
d1ξ
(
yP0100− yP0010
)
+ xˆP3 (t
∗) = 0
d3ξ
(
yP0101− yP1100
)
+ k2ξ
(
yP2000− yP1100
)
+ xˆP1 (t
∗)xˆP2 (t
∗) = 0
d3ξ
(
yP0011− yP1010
)
+ k1ξ
(
yP1100− yP1010
)
+ xˆP1 (t
∗)xˆP3 (t
∗) = 0
d2ξ
(
yP1010− yP0110
)
+ k1ξ
(
yP0200− yP0110
)
+ xˆP2 (t
∗)xˆP3 (t
∗) = 0
2d3ξ
(
yP1001− yP2000
)
+ ˆ
(
xP1
)2
(t∗) = 0
2d2ξ
(
yP1100− yP0200
)
+ ˆ
(
xP2
)2
(t∗) = 0
2d1ξ
(
yP0110− yP0020
)
+ ˆ
(
xP2
)2
(t∗) = 0
The optimal moment matrix Md(yP
∗
) is the obtained after the optimal moments, yP∗, are
computed by numerical solvers, e.g., CVX, Grant and Boyd (2015).
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MP
∗
= Md(yP
∗
) =

yP0000
∗ yP1000
∗ yP0100
∗ yP0010
∗ yP0001
∗
yP1000
∗ yP2000
∗ yP1100
∗ yP1010
∗ yP1001
∗
yP0100
∗ yP1100
∗ yP0200
∗ yP0110
∗ yP0101
∗
yP0010
∗ yP1010
∗ yP0110
∗ yP0020
∗ yP0011
∗
yP0001
∗ yP1001
∗ yP0101
∗ yP0011
∗ yP0002
∗
≥ 0
Finally, the feedback gains can be computed from the following system of linear equations:
M
P∗(2,5)
MP∗(3,5)
MP∗(4,5)
=
M
P∗(2,2) MP∗(2,3) MP∗(2,4)
MP∗(3,2) MP∗(3,3) MP∗(3,4)
MP∗(4,2) MP∗(4,3) MP∗(4,4)

K
P
1
KP2
KP3

(5.27)
The OCP formulated to find the remifentanil dose has the following structure,
min
uˆR(t),t f
J
(
xˆR(t), uˆR(t)
)
=
1
2
∫ t f
t∗
(
xˆR
)T
QxˆR(t)+
(
uˆR
)T
RuˆR(t)︸ ︷︷ ︸
hR(xˆR(t),uˆR(t))
dt
s.t. ˙ˆxR(t) = AR xˆR(t)+BR uˆR(t)︸ ︷︷ ︸
f R(xˆR(t),uˆR(t))
xˆR(t∗) =−(xR)e (5.28)
xˆR(t f ) = [0 0 0]
T
uˆR(t) ∈ G R =
{
uˆR(t) : uˆR(t)+
(
uR
)e ≥ 0, ∀t ≥ 0}
with xˆR(t) = xR(t)−(xR)e, uˆR = uR−(uR)e, xˆR0 =−(xR)e, the matrix AR and the vector BR
are defined by,
AR =
−η l3 0 0η l2 −η l2 0
0 η l1 −η l1
 and BR =
η l30
0
 , (5.29)
l1 = 1, l2 = 2 and l3 = 3, and the vector
(
xP
)e is equal to (xP)e [1 1 1]T with
(
uR
)e
=
ze
1
CP50
mρ+ 1CR50
(5.30)
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Again and for the same reason as before, the moment order was restricted to be d = 2 and
all possible combinations for the exponents of the test functions, v(xˆR) = xˆR1
β1
xˆR2
β2
xˆR3
β3
, are
indicated in Table 5.1. The equality constraint equations corresponding to the entries of the
Table 5.1 for the remifentanil model are,
l3η
(
yR0001− yR1000
)
+ xˆR1 (t
∗) = 0
l2η
(
yR1000− yR0100
)
+ xˆR2 (t
∗) = 0
l1η
(
yR0100− yR0010
)
+ xˆR3 (t
∗) = 0
l3η
(
yR0101− yR1100
)
+ l2η
(
yR2000− yR1100
)
+ xˆR1 (t
∗)xˆR2 (t
∗) = 0
l3η
(
yR0011− yR1010
)
+ l1η
(
yR1100− yR1010
)
+ xˆR1 (t
∗)xˆR3 (t
∗) = 0
l2η
(
yR1010− yR0110
)
+ l1η
(
yR0200− yR0110
)
+ xˆR2 (t
∗)xˆR3 (t
∗) = 0
2l3η
(
yR1001− yR2000
)
+ ˆ
(
xR1
)2
(t∗) = 0
2l2η
(
yR1100− yR0200
)
+ ˆ
(
xR2
)2
(t∗) = 0
2l1η
(
yR0110− yR0020
)
+ ˆ
(
xR2
)2
(t∗) = 0
The optimal moment matrix Md(yR
∗
) is the obtained after the optimal moments, yR∗, are
computed by numerical solvers, e.g., CVX, Grant and Boyd (2015).
MR
∗
= Md(yR
∗
) =

yR0000
∗ yR1000
∗ yR0100
∗ yR0010
∗ yR0001
∗
yR1000
∗ yR2000
∗ yR1100
∗ yR1010
∗ yR1001
∗
yR0100
∗ yR1100
∗ yR0200
∗ yR0110
∗ yR0101
∗
yR0010
∗ yR1010
∗ yR0110
∗ yR0020
∗ yR0011
∗
yR0001
∗ yR1001
∗ yR0101
∗ yR0011
∗ yR0002
∗
≥ 0
Finally, the feedback gains can be computed from the following system of linear equations:
M
R∗(2,5)
MR∗(3,5)
MR∗(4,5)
=
M
R∗(2,2) MR∗(2,3) MR∗(2,4)
MR∗(3,2) MR∗(3,3) MR∗(3,4)
MR∗(4,2) MR∗(4,3) MR∗(4,4)

K
R
1
KR2
KR3

(5.31)
In order to compare this approach with the one presented in Chapter 4 for the BIS case, the
following results were obtained using the same scenarios considered in the previous chapter.
First, we compare the performance of a controller designed with ξ = ξi, η = ηi, m=mi and
ζ = ζi with a controller designed with ξ = ξ¯ , η = η¯ , m = mi and ζ = ζi, i ∈ {1, . . . ,18}.
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The data set chosen corresponds to the patient number i = 8 of the database presented in
Appendix E.
In a second stage, a comparison will be made with the performance obtained of the patient
number 18 when the simplified control law of Chapter 4 is combined with the identification
method.
Scenario 1: Results obtained using ξ8, η8, m8 and ζ8 to design the controller:
The next results were obtained using ξ = ξ8 = 0.0860, η = η8 = 0.0212, m = m8 = 1.4203
and ζ = ζ8 = 0.9780 in the OCP formulations (5.24) and (5.28).
We considered that Q= 10×CTC, R= 10 and the value ρ in equation (5.26) was taken to be
equal to 500. For this data set, the optimal feedback gains for the propofol and remifentanil
models obtained by the solver, CVX Grant and Boyd (2015), are:
KPLMI =
[
−0.0320 −0.0407 −0.3396
]
KRLMI =
[
0.1601 0.0702 −0.5809
]
.
Figure 5.7 shows the simulation of the BIS level response obtained using a controller given
by the solution of the OCP formulations (5.24) and (5.28). As can be seen in Figure 5.7,
the control inputs uP(t) and uR(t) are always non-negative. It can be shown that, due to
the structure of the system, this implies that also the state components xP = xˆP + xre f P and
xR = xˆR + xre f R are non-negative. Therefore, the original problem constraints are indeed
satisfied.
Scenario 2: Results obtained using ξ¯ , η¯ , m8 and ζ8 to design the controller:
The next results were obtained using ξ = ξ¯ = 0.0759, η = η¯ = 0.5825, m = m8 = 1.4203
and ζ = ζ8 = 0.9780 in the OCP formulations (5.24) and (5.28). Again, the matrices of the
cost functional were assumed to be equal Q= 10×CTC, R= 10 and the value ρ in equation
(5.26) was taken to be equal to 500. For this data set, the optimal feedback gains for the
propofol and remifentanil models obtained by the solver CVX, Grant and Boyd (2015), are:
KPLMI =
[
−0.0318 −0.0408 −0.3396
]
KRLMI =
[
0.8299 0.1813 −0.1372
]
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Figure 5.7: Simulation of the BIS level response, yBIS, (upper plot) using the state-feedback control
(bottom plot) given by the moment relaxation method designed with ξ = ξ8 = 0.0860, η = η8 =
0.0212, m = m8 = 1.4203 and ζ = ζ8 = 0.9780.
Figure 5.8 shows the simulation of the BIS level response taking into account the previous
feedback gains. As can be seen in Figure 5.8, the control input signals uP(t) and uR(t) are
always non-negative and, consequently, the original problem constraints are indeed satisfied.
Figure 5.8: Comparison between the BIS level response, yBIS, (upper plot) using the state-feedback
control, u, (bottom plot) given by the moment relaxation method designed with ξ = ξ8 = 0.0860,
η =η8 = 0.0212, m=m8 = 1.4203 and ζ = ζ8 = 0.9780 and the BIS level ySCBIS using the simplified
state-feedback control uSC, i.e., using the state-feedback control designed with ξ = ξ¯ = 0.0759,
η = η¯ = 0.5825, m = m8 = 1.4203 and ζ = ζ8 = 0.9780.
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Finally, the control approach is combined with the parameter identification performed by
the EKF algorithm. The real case number 18 of Appendix E was used as in the previous
chapter. For this patient’s data the EKF algorithm identified m at the time instant t∗ = 4min
as 1.998 and ζ as 1.001. The matrices of the cost functional were assumed to be equal
Q = 10×CTC, R = 10 and the value ρ in equation (5.26) was taken to be equal to 500.
The optimal feedback gains for the propofol and remifentanil models obtained by the solver
CVX, Grant and Boyd (2015), are:
KPLMI =
[
−0.0326 −0.0404 −0.3397
]
KRLMI =
[
1.3064 −0.3480 −0.0883
]
Figure 5.9 shows the simulation of the BIS level response using the proposed control scheme
in this chapter. As can be seen in Figure 5.9, the control problem constraints, i.e., the
positivity of state and input signals, are satisfied.
Figure 5.9: Simulation of the BIS level response (upper plot) using the state-feedback con-
trol (bottom plot) given by the moment relaxation method designed using ξ = ξ¯ = 0.0759,
η = η¯ = 0.5825, m = m(t∗) = 1.998 and ζ = ζ (t∗) = 1.001. ∑uPSC+id and ∑uPreal represent
the propofol doses obtained by the simplified state-feedback controllers with parameter identifica-
tion and the ones obtained for the real cases (in clinical environment), respectively, and ∑uRSC+id
and ∑uRreal represent the remifentanil doses obtained by the simplified state-feedback controllers
with parameter identification and the ones obtained for the real cases (in clinical environment),
respectively.
Figure 5.10 shows the amount of drug given by the last controller compared with the real
amount of drug administered.
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As it is possible to see the amount of propofol given by the controller in lower than the
amount of drug given by the clinicians and the amount of remifentanil given by the con-
troller in higher than the amount of drug given by the clinicians. As it is possible to see in
Figure 5.11, the control approach stabilizes the BIS level near 40%, which is not close to the
suitable BIS reference level 50%. So, this approach control does not achieve the expected
desired value, but it still yields a BIS value that falls in a clinical admissible range, Gan et al.
(1997).
Figure 5.10: Total amount of propofol and of remifentanil administered during the surgery (red
star) and the total amount determined by the control scheme (blue bullet). ∑uPSC+id and ∑uPreal
represent the propofol doses obtained by the simplified controllers with parameter identification
and the ones obtained for the real cases (in clinical environment), respectively, and ∑uRSC+id
and ∑uRreal represent the remifentanil doses obtained by the simplified state-feedback controllers
with parameter identification and the ones obtained for the real cases (in clinical environment),
respectively.
The relationship between the amount of drug administered and the BIS level is computed
by the following cost functional as in the previous chapter,
Ji =
1
n
n
∑
t=0
((
yre fBIS− yBIS(t)
)2
+ κ
(
uP(t)+uR(t)
)2)
, i = 1, . . . ,8 (5.32)
Similarly to the other results, the cost functional for the proposed control is lower than the
real case as it is possible to see in Figure 5.12. So, we can conclude that the use of a
controller scheme is profitable.
In this chapter, control laws were designed that correspond to the solution of optimal control
problems. An optimal control problem was formulated for the control of the amount of
muscle relaxant that should be administered to achieve the NMB reference level. For the
BIS case, with the aim of controlling the amounts of hypnotic and analgesic, two optimal
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Figure 5.11: Mean of the real BIS level between the time instants ti and t f (red star) and mean of
the simulated NMB level in the same time interval (blue bullet). ti is the first time instant where the
response is lower than 50% and t f is the time instant when the surgery ends. ySC+idBIS represents the
mean of the BIS level between in the time interval [ti, t f ] obtained by the simplified state-feedback
control with parameter identification and yrealBIS represents the mean of the real BIS level between
in the same time interval.
Figure 5.12: Cost value obtained for the real cases (blue bullet) and the cost value obtained for
the control scheme (red star). JSC+id represents the cost value obtained using the signals obtained
by the simplified state-feedback control with parameter identification and Jreal represents the cost
value obtained using the real signals obtained during the general surgery.
control problems were considered. In both cases, the problems were solved by first replacing
the original variables by their moments up to a certain order. Then, the moments were
computed by the solver CVX, in order to obtain the feedback gains of the control law. The
performance of this control approach was analyzed by means of a cost functional which
involves both the amount of used drug and the reference tracking error. It turns out that the
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cost of our automatic controller is much lower than the one of manual drug administration
used in the real practice.
6Conclusions
This thesis focuses on the analyze of the feedback controllers of positive linear systems with a
static nonlinearity at the output in the context of anesthesia. The controllers presented in this
thesis were design based on simplified models, and consequently, present a simplified structure.
More concretely, two distinct control approaches were analyzed. One of the control approach
(presented in Chapter 4) consists in stabilizing what was called (with some abuse of language) the
"total system mass" into a desired reference value considering a positive control law designed for
compartmental system. The advantage of the first control scheme is the possibility of readjust-
ing the control by adjusting of the reference level during the process. The other control scheme
(presented in Chapter 5) is obtained by solving an optimal control problem. The main advantage
of this control law is the possibility of choosing the optimality criterion taking into account the
physiological patient condition.
Both approaches were combined with an algorithm for parameter identification in order to be
in accordance to what should happen in the real environment. The identification method used
was the Extended Kalman Filter. This algorithm was applied to identify the patient-dependent
parameters of the nonlinearity in the models.
The two aforementioned control approaches were applied to control two important compo-
nents of anesthesia: the neuromuscular blockade (NMB), and the depth of anesthesia which is
monitored by the bispectral level (BIS).
A comparison between the results obtained in Chapters 4 and 5 for the control of the NMB
level and BIS level is made then.
6.1 Comparison of the NMB case results
This section presents a comparison of the results obtained for the NMB case. For this purpose,
the cost function presented in Chapter 4 is used to compare the performance of the controller
approaches (with parameter identification).
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Recall that the cost function is given by the following equation:
J =
1
n
n
∑
t=0
((
yre fNMB− yNMB(t)
)2
+ κu2(t)
)
, (6.1)
with κ = 1.
This cost functional was computed using the signals obtained by the two different approaches
(of Chapters 4 and 5, respectively) and using the real signals collected during the actual surgeries.
In Figure 6.1 shows the values obtained using the simplified positive control law, JPCL, the ones
obtained by using the control given by solving the optimal control problem, JOCP, and the cost
functional obtained using the real signals, Jreal . As it is possible to see, the performance of the
second controller is better than the performance of the compartmental control law.
Figure 6.1: Cost value obtained for the control scheme when the controller is given by the positive
control law, JPCL, (red star), the cost value obtained for the control scheme when the controller is
the solution of the optimal control problem JOCP, (blue star) for the NMB level and the cost value
obtained using the real signals Jreal (green cross).
With this result we can conclude that both control strategies improve the trade-off between
the amount of the drug administered and the reference tracking of the NMB level when compared
with the real scenario. However, the controller obtained by solving the optimal control problem
presents a lower cost. Thus we can conclude that its implementation has more benefits in terms of
the amount of drug administered and the tracking of the reference NMB level.
6.2 Comparison of the BIS case results
Similarly to what was done in the previous section for the NMB level, here we compare the
performance of the control strategies when applied to the control of the BIS level.
6.3 Clinical environment 77
In this case, the functional cost is given by the equation:
J =
1
n
n
∑
t=0
((
yre fBIS− yBIS(t)
)2
+ κ
(
uP(t)+uR(t)
)2)
, (6.2)
Again, both strategies present a cost functional values lower than the values obtained using
the real signals. Hence, we can conclude that both strategies improve the trade-off between the
amount of drugs administered and the reference tracking of the BIS level when applied in the real
context. Comparing the two control approaches, the controller obtained by solving the optimal
control problem shows better results than the one obtained with the compartmental control law.
Figure 6.2: Cost value obtained for the control scheme when the controller is given by the positive
control law, JPCL, (red star), the cost value obtained for the control scheme when the controller is
the solution of the optimal control problem JOCP, (blue star) for the BIS level and the cost value
obtained using the real signals Jreal (green cross).
6.3 Clinical environment
The results obtained in this thesis support the incorporation of the state-feedback control ap-
proaches, with parameter identification, in clinical environment through the GALENO platform.
The GALENO platform was designed for automation in anesthesia during clinical practice
and simulation environment (from 2010 to 2013). It consists of a Matlab package that allows the
interface of control algorithms with medical equipment and is dedicated to the automatic control
of the neuromuscular blockade and of the depth of anesthesia. The current version of this platform
contains several control algorithms and system identification methods developed by the GALENO
project researchers. Namely, a controller designed in a previous work based on the reduced model,
Almeida et al. (2011), was included in this platform during the initial period of this thesis. This
controller has been widely used in surgery rooms.
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The extensive experience collected in clinical practice by using the aforementioned controller
provided a particular sensitivity and knowledge about the complex process of automation in anes-
thesia. The methods and techniques developed for the control approaches proposed in this thesis
were supported by this valuable and outstanding experience.
The implementation of the controller schemes proposed in this thesis both for neuromuscular
blockade and depth of anesthesia is still under construction.
6.4 Main contributions and future work
The main contributions of this thesis were the design and its implementation, in a simulation envi-
ronment, of two types of control laws for the reference tracking of the NMB and BIS levels during
general anesthesia, namely: simplified positive mass control laws, and control laws designed based
on suitable constrained optimal control problems that were solved using moment techniques.
As shown in Chapter 4, our simplified controller scheme has a similar performance as the pre-
viously proposed (non-simplified) control scheme using a positive mass control law based on the
reduced parameter model. In turn a comparison of the non-simplified mass-controllers with and
positive controllers based on PK/PD models has already been carried out in Almeida et al. (2011).
This comparison led to the conclusion that the former controllers have similar performance as
the latter, with the advantage of requiring the identification of fewer patient dependent parame-
ters. Other control schemes, eg., based on PIDs, have been proposed in the literature Mendonça
and Lago (1998), Lago et al. (1998). However their theoretical foundations, in particular in what
concerns the proof of the convergence to the desired reference level, have not been established
yet.Therefore here we have chosen only to compare the performance of the automatic controllers
developed in this thesis with each other and with the manual control administrated by the anes-
thetist. It turns out that the controlled designed based on optimal control performs better than the
simplified positive mass controller with respect to our cost function, while both of them perform
better than manual control.
Despite the promising results of these two approaches, there was no opportunity of implement-
ing them in clinical practice. In future work, the control schemes designed in this thesis should be
implemented in the GALENO platform and validated in the operation room.
Appendix A
PK/PD parameters for the atracurium -
NMB model
In Lago et al. (1998) a population model was proposed taking into account the works of Weatherley
et al. (1983) and Ward et al. (1983). The corresponding simulation models were obtained assuming
a multidimensional log-normal distribution for the pharmacokinetic and the pharmacodynamic
parameters in equations (2.3) and (2.4). This appendix includes the values of the parameters k10,
k12, k1e, ke0, k20, k21 [min−1] for 100 models.
Model k10 k12 k1e ke0 k20 k21 C50 γ
1 0.1774 0.3125 0.0036 0.1014 0.0000 0.1184 0.6527 3.9896
2 0.1205 0.1794 0.0022 0.0900 0.0000 0.0902 0.6769 3.9476
3 0.0799 0.0733 0.0010 0.0902 0.0000 0.0766 0.6240 3.1482
4 0.1283 0.1674 0.0024 0.0970 0.0000 0.1345 0.6742 4.3279
5 0.0897 0.0982 0.0011 0.0949 0.0000 0.0858 0.6435 4.7597
6 0.1244 0.1548 0.0025 0.1020 0.0000 0.0960 0.6311 4.2727
7 0.1375 0.2139 0.0029 0.0971 0.0000 0.1115 0.6655 4.1166
8 0.1335 0.1657 0.0028 0.1029 0.0000 0.0900 0.6697 3.7007
9 0.1397 0.2234 0.0030 0.0998 0.0000 0.0876 0.6398 4.0910
10 0.1047 0.1928 0.0017 0.0836 0.0000 0.1556 0.6620 4.2006
11 0.1925 0.2737 0.0037 0.1018 0.0000 0.0969 0.6097 5.1818
12 0.0974 0.1364 0.0019 0.1062 0.0000 0.0962 0.6545 4.4898
13 0.1103 0.1123 0.0031 0.1177 0.0000 0.0770 0.6066 4.3392
14 0.1115 0.1166 0.0022 0.0963 0.0000 0.1013 0.6563 5.3965
15 0.0876 0.1092 0.0013 0.0879 0.0000 0.1283 0.6456 5.0480
16 0.0566 0.0513 0.0008 0.0980 0.0000 0.0934 0.6234 4.3575
17 0.1321 0.2148 0.0024 0.1022 0.0000 0.1170 0.6393 4.7257
18 0.1465 0.1881 0.0037 0.1075 0.0000 0.0887 0.6125 3.8534
19 0.1327 0.1811 0.0024 0.0946 0.0000 0.0919 0.7091 3.3303
20 0.1120 0.2281 0.0017 0.0928 0.0000 0.1193 0.6849 4.7091
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Model k10 k12 k1e ke0 k20 k21 C50 γ
21 0.1238 0.2225 0.0021 0.0907 0.0000 0.1290 0.6405 5.4086
22 0.0963 0.1213 0.0014 0.0923 0.0000 0.1160 0.6975 4.2585
23 0.1900 0.3681 0.0040 0.1107 0.0000 0.1156 0.6506 3.5436
24 0.0482 0.0171 0.0010 0.1116 0.0000 0.1468 0.6605 4.5706
25 0.1489 0.2881 0.0026 0.0892 0.0000 0.1400 0.6452 3.5223
26 0.1852 0.4011 0.0045 0.1003 0.0000 0.1433 0.6716 3.7446
27 0.1416 0.2297 0.0027 0.0904 0.0000 0.0986 0.6202 4.6149
28 0.1349 0.2371 0.0022 0.0936 0.0000 0.1273 0.6344 5.0500
29 0.0878 0.1541 0.0015 0.0986 0.0000 0.1402 0.6651 3.4746
30 0.1234 0.1584 0.0026 0.0996 0.0000 0.1421 0.6548 3.9473
31 0.1310 0.3080 0.0016 0.0850 0.0000 0.1545 0.6229 4.2800
32 0.1435 0.2061 0.0028 0.0928 0.0000 0.1246 0.6650 4.3926
33 0.1181 0.2236 0.0026 0.1056 0.0000 0.1550 0.6653 4.5267
34 0.0782 0.0766 0.0012 0.1055 0.0000 0.0783 0.6262 4.2578
35 0.1668 0.2349 0.0034 0.1016 0.0000 0.0947 0.6499 4.5096
36 0.1115 0.2591 0.0020 0.0938 0.0000 0.1338 0.6533 4.4695
37 0.0879 0.0852 0.0019 0.1042 0.0000 0.0944 0.6603 3.7671
38 0.1223 0.1194 0.0019 0.0853 0.0000 0.0779 0.6624 4.2315
39 0.1199 0.1484 0.0022 0.0953 0.0000 0.1079 0.6161 3.9712
40 0.1213 0.1323 0.0021 0.0973 0.0000 0.0939 0.6500 4.6327
41 0.1847 0.3332 0.0035 0.0928 0.0000 0.0921 0.6599 3.2811
42 0.0820 0.0595 0.0018 0.1077 0.0000 0.0962 0.6955 4.4275
43 0.1450 0.1850 0.0031 0.1039 0.0000 0.0919 0.6517 3.5224
44 0.0984 0.1937 0.0019 0.1032 0.0000 0.1195 0.6941 4.2905
45 0.1292 0.2144 0.0029 0.1019 0.0000 0.1303 0.6427 4.0431
46 0.0924 0.2195 0.0015 0.1028 0.0000 0.1627 0.6610 4.2986
47 0.0967 0.1366 0.0020 0.1068 0.0000 0.1223 0.6587 3.8199
48 0.1115 0.1398 0.0026 0.1028 0.0000 0.0901 0.6491 4.3942
49 0.0898 0.1442 0.0016 0.0951 0.0000 0.1378 0.6372 4.0812
50 0.1218 0.1962 0.0020 0.0857 0.0000 0.1268 0.6451 4.4704
51 0.1702 0.1668 0.0028 0.0905 0.0000 0.0640 0.6606 3.8730
52 0.0842 0.0866 0.0014 0.0997 0.0000 0.0918 0.6622 4.6127
53 0.1460 0.2514 0.0019 0.0900 0.0000 0.1112 0.6714 3.9129
54 0.1370 0.2256 0.0023 0.0888 0.0000 0.1185 0.6549 4.4047
55 0.1122 0.1623 0.0020 0.1012 0.0000 0.1341 0.6031 3.3747
56 0.1247 0.1974 0.0023 0.1093 0.0000 0.1332 0.6732 4.9630
57 0.1041 0.2139 0.0019 0.0928 0.0000 0.1616 0.6747 3.7667
58 0.1302 0.2279 0.0025 0.1038 0.0000 0.1329 0.6272 4.3128
59 0.1045 0.1505 0.0023 0.1132 0.0000 0.1117 0.6461 4.9081
60 0.1084 0.2048 0.0016 0.1033 0.0000 0.1457 0.6315 4.9170
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Model k10 k12 k1e ke0 k20 k21 C50 γ
61 0.1161 0.1674 0.0019 0.1010 0.0000 0.1137 0.6703 3.9240
62 0.1459 0.3182 0.0026 0.0993 0.0000 0.1360 0.6271 5.2428
63 0.0862 0.0753 0.0015 0.1012 0.0000 0.0826 0.5964 3.6932
64 0.1447 0.1877 0.0041 0.1284 0.0000 0.0853 0.6174 4.0606
65 0.1000 0.1246 0.0018 0.1025 0.0000 0.1078 0.6406 4.0815
66 0.1362 0.1847 0.0025 0.1067 0.0000 0.1033 0.6382 2.8659
67 0.1086 0.1302 0.0016 0.0957 0.0000 0.1075 0.6918 4.6857
68 0.1173 0.1698 0.0023 0.1007 0.0000 0.1013 0.6630 4.0857
69 0.0919 0.1365 0.0015 0.0962 0.0000 0.0983 0.6568 4.3558
70 0.1300 0.2155 0.0026 0.1029 0.0000 0.1237 0.6335 4.8719
71 0.0759 0.0649 0.0015 0.1009 0.0000 0.0902 0.6673 3.5112
72 0.2437 0.1614 0.0065 0.0975 0.0000 0.0481 0.6382 4.2303
73 0.1882 0.1927 0.0043 0.0985 0.0000 0.0771 0.6466 4.5427
74 0.1198 0.2061 0.0023 0.1009 0.0000 0.1148 0.6459 4.3404
75 0.1117 0.3284 0.0019 0.0904 0.0000 0.1672 0.6454 3.9773
76 0.0930 0.1434 0.0018 0.1090 0.0000 0.0993 0.5972 3.2956
77 0.1744 0.2811 0.0032 0.1065 0.0000 0.1070 0.6433 5.2459
78 0.0790 0.0562 0.0013 0.1117 0.0000 0.0756 0.6448 3.7874
79 0.1872 0.3480 0.0041 0.1075 0.0000 0.1037 0.6102 3.3890
80 0.0958 0.2025 0.0017 0.0955 0.0000 0.1326 0.6331 4.0243
81 0.1108 0.1855 0.0017 0.0930 0.0000 0.1108 0.6344 4.3891
82 0.1605 0.2562 0.0037 0.1005 0.0000 0.0983 0.6767 4.5957
83 0.0862 0.1163 0.0014 0.0929 0.0000 0.1312 0.6756 4.0209
84 0.1838 0.3813 0.0035 0.0948 0.0000 0.1085 0.6528 4.0483
85 0.0866 0.1152 0.0014 0.0901 0.0000 0.1313 0.5771 4.7046
86 0.1050 0.1912 0.0021 0.1020 0.0000 0.1193 0.6975 4.1069
87 0.1427 0.3536 0.0036 0.1003 0.0000 0.2232 0.6386 4.4922
88 0.0794 0.0712 0.0014 0.1019 0.0000 0.0876 0.6499 3.9735
89 0.1268 0.1750 0.0027 0.1059 0.0000 0.0859 0.6424 3.5674
90 0.2016 0.4729 0.0041 0.1001 0.0000 0.1328 0.6418 4.5014
91 0.1005 0.1230 0.0018 0.0994 0.0000 0.0991 0.6331 5.2730
92 0.1336 0.3644 0.0025 0.0892 0.0000 0.1777 0.6550 4.3442
93 0.1065 0.1434 0.0019 0.1020 0.0000 0.1284 0.6574 5.7029
94 0.2200 0.3158 0.0043 0.0932 0.0000 0.0978 0.6319 4.3254
95 0.1077 0.1059 0.0016 0.0911 0.0000 0.1013 0.6495 4.1183
96 0.1158 0.1709 0.0019 0.1014 0.0000 0.0935 0.6192 3.6866
97 0.1489 0.3262 0.0020 0.0920 0.0000 0.1588 0.6472 4.4492
98 0.1343 0.2337 0.0028 0.1064 0.0000 0.1296 0.6900 3.4982
99 0.1750 0.1562 0.0037 0.0911 0.0000 0.0742 0.6782 4.5144
100 0.1631 0.2333 0.0029 0.1000 0.0000 0.1081 0.6250 4.1006
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Appendix B
Parameters values for the reduced NMB
model
In Rocha et al. (2013) a population model was proposed for the reduced model for the NMB
level, and 100 simulation models were obtained assuming a bivariate normal distribution for the
parameters α and γ . These are listed in the following tables.
Model α γ
1 0.0448 2.2464
2 0.0412 2.9740
3 0.0378 1.8559
4 0.0395 2.0250
5 0.0335 4.5410
6 0.0487 1.8050
7 0.0377 2.8611
8 0.0495 1.3061
9 0.0389 2.2749
10 0.0428 1.8861
11 0.0298 2.8826
12 0.0335 3.9565
13 0.0454 3.1812
14 0.0338 4.1824
15 0.0409 2.6325
16 0.0353 3.2642
17 0.0366 1.9262
18 0.0303 2.6834
19 0.0306 4.6375
20 0.0436 3.1933
Model α γ
21 0.0371 3.0894
22 0.0330 1.9503
23 0.0332 3.2284
24 0.0428 2.7471
25 0.0370 2.3554
26 0.0405 2.7678
27 0.0398 5.8448
28 0.0421 2.1138
29 0.0398 1.5159
30 0.0303 1.3093
31 0.0396 2.0012
32 0.0445 1.8909
33 0.0419 1.6837
34 0.0258 6.7175
35 0.0358 3.7614
36 0.0355 3.4349
37 0.0393 2.9484
38 0.0345 1.1170
39 0.0374 4.5999
40 0.0480 2.2479
Model α γ
41 0.0427 1.8126
42 0.0390 1.3337
43 0.0323 3.0455
44 0.0370 5.2768
45 0.0382 2.9523
46 0.0343 3.7325
47 0.0355 2.6102
48 0.0399 3.5523
49 0.0477 1.3675
50 0.0255 4.7934
51 0.0315 3.5767
52 0.0445 2.2160
53 0.0409 2.6649
54 0.0358 4.5971
55 0.0399 2.5732
56 0.0321 3.9677
57 0.0319 1.9665
58 0.0393 3.7719
59 0.0474 4.0478
60 0.0420 2.0308
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Model α γ
61 0.0345 2.0376
62 0.0429 1.7712
63 0.0359 3.4293
64 0.0334 2.2653
65 0.0349 2.7179
66 0.0340 1.8141
67 0.0362 3.8102
68 0.0408 1.9596
69 0.0316 3.9868
70 0.0395 3.2793
71 0.0446 2.2267
72 0.0383 2.8910
73 0.0417 2.2215
74 0.0371 2.3825
75 0.0512 3.0818
76 0.0432 2.4374
77 0.0281 2.2937
78 0.0376 4.4079
79 0.0282 2.3291
80 0.0439 2.7248
Model α γ
81 0.0397 1.9430
82 0.0413 2.2453
83 0.0428 2.7501
84 0.0491 3.0762
85 0.0355 2.4771
86 0.0366 3.0201
87 0.0411 2.3179
88 0.0435 2.4034
89 0.0314 2.0571
90 0.0343 2.7195
91 0.0376 4.2942
92 0.0254 2.6901
93 0.0448 1.5388
94 0.0318 4.9773
95 0.0447 3.4159
96 0.0330 3.7567
97 0.0413 1.5494
98 0.0425 4.0200
99 0.0364 2.2434
100 0.0408 1.6940
Appendix C
Real doses of atracurium and the
corresponding NMB level
The following figures show the real NMB level obtained during ten general anesthesias and the
administered atracurium dose given by the anesthesiologist.
1. Female patient with 82 year-old
Figure C.1: NMB level and the atracurium dose profile of the patient number 1.
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2. Female patient with 45 year-old
Figure C.2: NMB level and the atracurium dose profile of the patient number 2.
3. Female patient with 71 year-old
Figure C.3: NMB level and the atracurium dose profile of the patient number 3.
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4. Female patient with 32 year-old
Figure C.4: NMB level and the atracurium dose profile of the patient number 4.
5. Female patient with 49 year-old
Figure C.5: NMB level and the atracurium dose profile of the patient number 5.
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6. Female patient with 69 year-old
Figure C.6: NMB level and the atracurium dose profile of the patient number 6.
7. Male patient with 47 year-old
Figure C.7: NMB level and the atracurium dose profile of the patient number 7.
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8. Male patient with 86 year-old
Figure C.8: NMB level and the atracurium dose profile of the patient number 8.
9. Male patient with 37 year-old
Figure C.9: NMB level and the atracurium dose profile of the patient number 9.
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10. Male patient with 68 year-old
Figure C.10: NMB level and the atracurium dose profile of the patient number 10.
Appendix D
PK/PD parameter values for the BIS
model
D.1 Schneider and Minto models
As mentioned, the PK/PD models used to simulate the BIS level take into account patient’s infor-
mation as the age, height, weight and gender. The models presented in the literature for propofol
are Marsh’s model, Marsh et al. (1991) and Schnider’s model, Schnider et al. (1998), whereas for
the opioid remifentanil Minto’s model, Minto et al. (1997), is adapted. Here, Schnider’s model
and Minto’s model will be considered since that were the ones used in Chapter 2.
Note that, for both models the lean body mass (LBM) is computed as:
• Male: 1.10×weight−128×
(
weight
height
)2
• Female: 1.07×weight−148×
(
weight
height
)2
D.1.1 Schnider’s model
The dynamic system that describes the exchange of the mass concentration between the compart-
ments is represented by a state-space model with the following structure:
x˙(t) =

−(k10+ k12+ k13) k21 V2V1 k31
V3
V1
0
k12 V1V2 −k21 0 0
k13 V1V3 0 −k30 0
0 0 0 −ke0
 +

1
V1
0
0
0
u(t)
ce(t) =
[
0 0 0 1
]
x(t) (D.1)
The value of the parameters are obtained using the following equations, Schnider et al. (1998),
• V1 = 4.27
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• V2 = (18.9−0.391× (age−53))
• V3 = 238
• k10 = 0.443+0.0107× (weight−77)−0.0159× (LBM−59)+0.0062× (height−177)
• k12 = 0.302−0.0056× (age−53)
• k13 = 0.196
• k21 = 1.29−0.024×(age−53)18.9−0.391×(age−53)
• k31 = 0.0035
• ke0 = 0.456
D.1.2 Minto’s model
The dynamic model is equal to the one presented above (D.1) and the parameter values are ob-
tained as, Minto et al. (1997),
• V1 = 5.1−0.0201× (age−40)+0.072× (LBM−55)
• V2 = 9.82−0.0811× (age−40)+0.108× (LBM−55)
• V3 = 5.42
• k10 = 2.6−0.0162×(age−40)+0.0191×(LBM−55)V1
• k12 = 2.05−0.0301×(age−40)V1
• k13 = 0.076−0.00113×(age−40)V1
• k21 = k12× V1V2
• k31 = k13× V1V3
• ke0 = 0.595−0.007× (age−40)
D.2 Database
The following table presents the data collected from 18 patients (gender, age, height, weight) as
well as the corresponding parameters for the Hill equation. These latter were obtained using a
hybrid method for parameter estimation presented in Mendonça et al. (2012).
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Patient Gender Age Height (cm) Weight (kg) CP50 C
R
50 β γ
1 F 56 160 88 13.9395 41.6474 2.0321 3.3266
2 F 48 158 52 13.8766 40.2121 1.0133 3.3845
3 F 51 165 55 20.0000 28.2501 2.0196 2.3133
4 F 56 160 65 20.0000 52.2481 1.8930 3.2273
5 F 64 146 60 14.8483 99.9985 1.0702 2.9505
6 F 59 159 110 20.0000 89.0323 2.6169 3.3774
7 F 29 163 59 17.0831 61.0269 3.7297 3.1494
8 F 45 155 58 3.3464 100.0000 0.9172 0.0000
9 F 51 163 55 12.1717 31.1256 1.8645 2.8367
10 F 32 172 56 16.9091 13.7576 1.4517 2.7978
11 F 68 160 64 15.5170 100.0000 0.9334 3.4496
12 F 50 161 68 20.0000 100.0000 1.6649 3.2860
13 F 68 158 113 5.4124 34.6043 0.9882 2.8094
14 F 70 161 78 7.1976 36.6864 3.8213 2.2302
15 F 73 160 75 12.4128 16.3676 1.6771 2.4726
16 F 34 162 57 20.0000 46.0490 3.9302 2.9983
17 F 43 155 62 20.0000 49.7593 1.6096 3.2064
18 F 66 155 74 3.4326 99.9999 1.5613 3.2411
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Appendix E
Parameters values for the reduced BIS
model
The table presented here contains the parameter values for the reduced BIS model that were iden-
tified in Mendonça et al. (2012), for the 18 patients in the database presented in Appendix D,
Section D.2.
Patient ξ η m ζ
1 0.0667 0.3989 2.1502 1.7695
2 0.0874 0.0670 4.7014 0.9365
3 0.0693 0.0482 1.1700 2.8186
4 0.0590 0.0425 1.4077 2.7594
5 0.0489 0.1269 1.4171 1.5627
6 0.0677 0.3373 1.1444 4.1247
7 0.0737 0.2793 0.8986 0.7812
8 0.0860 0.0212 1.4203 0.9780
9 0.0701 0.2837 1.2164 1.0956
10 0.1041 0.1038 1.9085 1.2165
11 0.0343 3.5768 2.5451 1.7097
12 0.0467 0.1254 1.4884 2.4877
13 0.0687 4.5413 2.3951 1.0859
14 0.0774 0.0397 1.5460 1.4038
15 0.0995 0.0377 2.0485 1.3706
16 0.0929 0.1205 1.5565 4.5194
17 0.0811 0.1033 2.0338 2.1978
18 0.1336 0.2307 1.2061 1.0846
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